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The work described herein is centered on reductive methylation, a chemical modification 
reaction, which allows for the introduction of methyl groups at the primary amines of the lysine 
side chain and at the N-terminus. The resulting methyl groups are effective probes for the study 
of protein structure and dynamics using nuclear magnetic resonance spectroscopy (NMR). 
Described herein is work conducted on the development of tools for the study of protein 
structure using reductive methylation, highlighting options for addressing limitations of the 
labeling method encountered by its practical use.  
Chapter 1 serves as a brief introduction to protein structure and the modification of 
protein structure, both biological and chemical. This chapter sets the stage for the remaining 
chapters by establishing the importance of structural studies and how the reductive methylation 
reaction has been useful to this end. Chapter 2 details work done towards the development of a 
method to make assignments of NMR peaks of a reductively methylated protein. The method 
described focuses on addressing the issue of degenerate labeling associated with the reaction, 
which results in similar degrees of methylation at the reaction sites. The method presented 
involves the introduction of solid chromatographic media into the reaction and using 
substoichiometric concentrations of the modifying reagents in order to introduce more variation 
in the labeling of the reaction sites. The overall objective of this project is to investigate if the 
introduction of the media and the change in reagent concentration would help to overcome the 
degenerate labeling and enable more definitive peak assignments. In chapter 3, methods were 
developed by modifying the sample environments to achieve more resolved and intense NMR 
peaks of reductively methylated protein. The improvement of resolution and intensity aids peak 
xx 
 
fitting for accurate peak area calculations, which are used in the determination of percent 
labeling at each dimethylamine peak in the NMR spectra. Chapter 4 details a study where the 
overall objective is to investigate the effects of reductive methylation on the determination of 
protein concentration by the Bradford and Bicinchoninic acid (BCA) assays. The development of 
a novel use of reductive methylation coupled with paramagnetic relaxation enhancement (PRE) 
NMR spectroscopy is detailed in Chapter 5 for the determination of the quaternary structural 
complex of a cysteine protease, papain, and a cysteine protease inhibitor. Chapter 6 will discuss 




INTRODUCTION TO THE MODIFICATION OF PROTEINS FOR NMR 
STRUCTURAL STUDIES 
1.1. The Role of Proteins in Biological Systems 
Proteins play pivotal roles in the execution, completion, and inhibition of all biological 
processes.1 Their versatility is shown by the variety of functions they serve in the body where 
they act as cell signalers, defenders of the body, maintainers of biological structures, regulators 
and transporters, modes of storage, aids in cell motility, and catalysts.2 In cell signaling 
pathways, they often act as channels for the intracellular and extracellular transduction of 
signals.3-4 When acting as antibodies, proteins help to keep the body healthy by defending 
against antigens.5 As maintainers of structure, proteins help to keep cellular components intact 
and are structurally fundamental to other highly ordered body components, such as keratin, the 
primary component found in hair and nails.6 Proteins can also act as regulators and transporters, 
controlling metabolic processes such as insulin production and the transport of materials across 
membranes.7 As storage vessels, proteins keep reserves of ions and other amino acids necessary 
for the full functioning of organisms, such as ferritin, a protein that stores iron for hemoglobin.8-9 
They also have an active role in cellular motility and are responsible for actions such as the 
contraction and extension of skeletal muscle.10 As catalysts, proteins participate in enzymatic 
pathways by lowering the activation energy to increase the rate of the reaction. While this 
introduction is by no means a comprehensive presentation of the functional roles of proteins in 
the body, it does highlight the diverse nature of protein function, which is directly related to the 
amino acid composition and 3-dimensional (3D) structure of proteins. 
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1.2. Protein Structure 
1.2.1. Amino Acids: The Building Blocks 
Proteins are biological polymers, comprising a combination of 20 amino acids. The 
generic structure of an amino acid consists of a central carbon atom, referred to as the alpha 
carbon.  This central carbon is bound to four different groups: a hydrogen atom (alpha), an amino 
group, a carboxyl group, and a unique side chain or “R” group.11 The generic structure of an 








The individual chemical properties of each of the amino acids are attributed to the unique 
side chain that influences both the behavior of the amino acid and the protein itself in different 
environments. In general, amino acids can be classified as either polar (hydrophilic) or nonpolar 
(hydrophobic). Nonpolar amino acids are characterized by their aliphatic side chains. However, 
there are a few exceptions, including tyrosine, glycine, and proline, which are nonpolar even 
though their side chains are not aliphatic in nature. The amino acid, tyrosine, has a side chain 
containing an aromatic ring while glycine has a hydrogen atom, and proline has a unique ring 
structure that incorporates the alpha carbon and the amine group. The polar amino acids are 
characterized by their propensity to interact with aqueous solutions with some carrying an 
 
Figure 1.1. Generic structure of an amino acid. 
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overall charge. This charge allows for electrostatic interactions and hydrogen bonding in the 
presence of charged solutions or surfaces. 
Depending on the surrounding environment, some side chains can behave as either proton 
donors (acidic) or proton acceptors (basic). The susceptibility to donate or accept a proton is 
measured by the negative logarithm of the acid dissociation constant, denoted as pKa. Each free 
amino acid has at least two acid dissociation constants associated with the amino group and the 
carboxyl group, both of which can be ionized. Amino acids with ionizable side chains (arginine, 
lysine, histidine, cysteine, tyrosine, aspartic acid, and glutamic acid) have a third dissociation 
constant, which is associated with the respective side chain. The pKa value of an amino acid 
corresponds to the pH at which the concentration of the protonated form of the ionizable moiety 
is equal to the deprotonated form. When the pH is lower than the pKa, the protonated form 
dominates. Conversely, if the pH is higher than the pKa, the deprotonated form dominates. 
Amino acids having both positive (amine) and negative (carboxyl) charges can have a 
neutral net charge and are zwitterions. The pH where this occurs is the isoelectric point (pI) and 
occurs halfway between the pKa values of the amine and carboxyl groups (if there is no third 
dissociation constant). For amino acids with ionizable side chains, the pI is the average of the 
pKa of the side chain and the pKa of either the amino group (if the amino acid is basic) or the 
carboxyl group (if the amino acid is acidic). The pI of a protein is calculated based on the amino 
acid composition and indicates a pH where the net charge of the overall protein is neutral. 
Additionally, the pI value acts as a gauge for protein stability in aqueous solution, where 
typically within ±1 pH unit of the pKa value, the protein is unstable. Similar to the pKa, when the 
pH is lower than the pI, the protein will have a net positive charge. Conversely, when the pH is 
higher than the pI, the protein will have a net negative charge. The full listing of each amino 
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acid, their abbreviations, acid dissociations constants for the amine, carboxyl, and side chains, 
and isoelectric point are listed in Table 1.1. In addition, Figure 1.2 illustrates the structure of 
each amino acid.  These amino acid properties dictate the overall character of the protein and are  
used to predict protein behavior when the protein is in contact with polar and nonpolar solutions 
and surfaces. In addition, they are important because they dictate the folding of the protein into 
its more sophisticated 3D structure.12 
1.2.2. Levels of Protein Structure 
The linear sequence of amino acids in a protein, called the primary structure (1°), 
influences the folding of the polypeptide chain into its secondary, tertiary, and quaternary 
protein structures. The amino acids of the primary structure are held together by covalent 
peptide bonds, which are formed by the loss of a water molecule when the carboxyl group of the 
preceding amino acid joins the amino group of the subsequent amino acid. The secondary 
structure (2°) of proteins is formed by various interresidue interactions, such as hydrogen 
bonding, to create the predominating secondary structures, -helices and -sheets.13-15 Less 
structured 2° structural motifs include coils, turns, and loops. The tertiary structure (3°) of 
proteins is the folding of a single peptide chain onto itself as a result of long-range 
intramolecular interactions such as ionic bond formation, hydrophobic interactions, disulfide 
bonds, hydrogen bonds, and salt bridges.16 The quaternary structure (4°) of proteins refers to the 
interaction of two or more polypeptide chains, known as subunits. Figure 1.3 illustrates the 
levels of protein structure. 
*Adapted from Handbook of Chemistry and 
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Figure 1.2. Amino acid structures. 
Glutamic Acid Glutamine Glycine IsoleucineHistidine
Leucine Lysine Methionine Phenylalanine Proline
Alanine Asparagine Aspartic Acid CysteineArginine 
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structure is necessary for binding interactions that are oftentimes pivotal in the execution and/or 
inhibition of metabolic processes. Thus, it is safe to assume that protein structural studies will 
provide further insight to protein function. 
1.3. Protein Synthesis 
Deoxyribonucleic acid (DNA) is the genetic code for living organisms and acts as a 
blueprint for the production of biological components including proteins.1 The variation in these 
codes ensures the differentiation of the proteins produced. Genes, which encode for protein 
production, participate in protein synthesis. Protein synthesis can be described in two main steps: 
(1) transcription and (2) translation.18 Transcription occurs through a series of events, the first of 
which is initiation. During initiation, DNA is unwound by transcription factors, allowing for the 
attachment of the enzyme, ribonucleic acid (RNA) polymerase, to the DNA strand. The second 
event, elongation, is characterized by the continuous movement of RNA polymerase down the 
DNA strand, copying the cell’s DNA into an antiparallel strand of messenger RNA (mRNA), 
which encodes for a specific protein. The RNA polymerase continues to replicate the DNA until 
it reaches a termination sequence. The RNA polymerase and newly synthesized mRNA strand 
are released from the DNA, and the DNA returns to its double helix conformation. The mRNA 
sequence is comprised of the nucleic acids adenine (A), cytosine (C), guanine (G) and uracil (U), 
which is substituted for the thymine (T) found in DNA. mRNA is transported to the cytoplasm 
and binds to the ribosomes for protein translation. Protein translation can also be broken down 
into a series of events, the first of which is initiation. Initiation involves the attachment of the 
mRNA to the ribosome at the start codon of the sequence, AUG. Next, the ribosome continues to 
produce a complimentary strand to the mRNA, two codons at a time. From this complementary 
strand, the amino acid sequence is determined by the transfer RNA (tRNA) that binds to each 
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codon presented by the ribosome. Each codon, a sequence of three nucleic acids, represents a 
specific amino acid. The amino acids associated with the sequential codons are bound together 
through peptide bonds; this step is referred to as elongation. The elongation step continues until 
the ribosome reaches a stop codon (UAG, UAA, UGA) and dissociation of the mRNA from the 
ribosome occurs. The resulting amino acid sequence is the primary structure of the protein. 
While protein synthesis is complete, the protein will likely undergo post-translational 
modifications (PTMs) in preparation for its intended function.  
1.4. Protein Modifications 
1.4.1. Post-Translational Modifications (PTMs) 
The human genome project suggested that the genome is only comprised of 20-25 
thousand genes in comparison to the human proteome, which is much more complex with over 1 
million proteins.19-22 While gene transcription and translation yields the basic protein structure, 
the PTM of a protein often dictates its function, conformation, localization, and interactions with 
other molecules. Thus, the diversification of proteins by the addition of PTMs increases the 
heterogeneity of the proteome.23  
PTMs can be simply defined as property altering reactions, occurring by proteolytic 
cleavage or the addition of a modifying group to one or more of the amino acids, and can be 
classified as site specific.24 More than 300 PTMs have been identified, and they all have specific 
metabolic functions.25-27 PTMs fall into three major categories based on their mode of protein 
modification. The first category includes modifications involving the formation or cleavage of 
peptide bonds. The second categorizes modifications that occur at the amino (N-) or carboxyl  
(C-) terminal amino acids. The third category, which falls under the scope of this dissertation, 
involves modifications of specific amino acid side chains.28  
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1.4.2. Side Chain Specific Modifications 
PTMs, which modify specific side chains, are further sub-categorized by the 
modification’s function. The first category involves modifications that yield precursors for 
specific non-covalent protein and polypeptide interactions. An example of this type of PTM is 
glycosylation. Glycosylation is defined as the addition of a sugar moiety to a protein. One of the 
primary purposes of such a modification is to facilitate the binding of the protein to the surface 
of cells and other intracellular membranes.29-32 A second category encompasses PTMs, which are 
the result of the insertion of chemical constituents serving as cofactors or prosthetic groups. 
These types of modifications are important because cofactors are often required for a protein’s 
full functionality; thus, the cofactors are often “helper” molecules assisting the enzyme in 
biological interactions. The manner in which the cofactors are bound, covalently versus non-
covalently, often dictate the enzyme’s specificity.28, 33-35 A third category deals with 
modifications that aid in crosslinking and the stabilization of protein matrices. An example of 
this modification is the extracellular crosslinking that occurs in keratin and collagen. Another 
example is the stabilization of keratin matrices by -glutamyl crosslinking.36-43 The fourth 
category encompasses modifications resulting in the creation of new binding sites for metals, 
hydrogen, water, or result in a change in aromaticity.16, 44-46 The fifth and final category consists 
of modifications that are reversible, covalent modifications that directly control specific 
enzymatic and regulatory events. Protein methylation falls within this subcategory. Biologically, 
methylation can act as an on/off switch for metabolic processes and occurs at the basic residues: 
histidine, arginine, and lysine.47-48 In order to study these modifications and their influence on 
protein structure and function, one must be able to produce properly folded, modified protein on 
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a larger scale than the amount produced in vivo. This production is achieved through a process 
known as recombinant protein expression. 
1.5. Recombinant Protein Expression 
Decades of research in the field of genetic engineering have resulted in a multitude of 
options for recombinant protein expression of both prokaryotic and eukaryotic proteins. The 
technology of recombinant expression allows for the overexpression of proteins in systems, 
which have a rapid growth rate and are easily cultivated. The use of bacterial hosts, like E. coli, 
is prevalent because it is cost effective, E. coli genetic information is well studied, E. coli is 
easily manipulated, and E. coli has a rapid growth rate with high protein yields.49-51 The 
expression in recombinant systems results in the production of protein that are used for highly 
application driven biochemical and structural studies of proteins.52-53 In addition, many of the 
protein structures published within the last decade were expressed in E. coli.54 However, there 
are some marked limitations to the expression of eukaryotic proteins in E. coli systems. One such 
limitation is the bacteria’s decreased ability to produce properly folded eukaryotic proteins. This 
limitation results from a lack of protein chaperones necessary for proper folding.55 In addition, 
the system lacks the ability to incorporate PTMs on eukaryotic proteins.49, 56-57 Structural studies 
of proteins by NMR demands the incorporation of isotopic labeling to the expressed protein. 
Although uniform labeling with 13C and 15N isotopes is achieved during expression, this 
technique can be expensive, especially when using hosts other than E. coli. In addition, the 
incorporation of most site-specific modifications cannot be achieved.58-59 Thus, a solution to this 
limitation is the incorporation of chemical modifications.60  
Chemical modification of proteins takes advantage of the side chain reactivity in order to 
incorporate modifications that mimic biological modifications. The scope of this dissertation is 
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focused on the chemical modification of the lysine residues. The next section will discuss the 
chemical modification of proteins, followed by a more focused discussion of both the chemical 
modification of lysine residues and a specific lysine modifying reaction known as reductive 
methylation. 
1.6. Chemical Side Chain Modification of Proteins 
Chemical side chain modification is defined as the stoichiometric modification of 
proteins at specific residues without modifying other sites. The development of methods to 
chemically modify proteins has progressed over the past 80 years, through developments in the 
fields of analytical, physical, and organic chemistry.61 While many of the initial uses centered on 
the determination of the functionality and the importance of the modified amino acids, 
methodologies that are more recent find applicability in the areas of proteomics, structural 
biology, and chemical biology.62-65 Like the biological modifications of proteins, chemical 
modifiers illicit changes to the protein structure, mimicking in vivo modifications and targeting 
the reactive functional groups of the side chains.66-72 There are several factors in the development 
of chemical modification reactions; thus, some amino acids are preferentially targeted over 
others. Some of the more targeted amino acids include those with aromatic heterocycles 
(tryptophan and histidine), phenols (tyrosine), sulfhydryls (cysteine and the thioester of 
methionine), and nitrogen containing groups such as amines (arginine and lysine) and amides 
(glutamine and asparagine). Two side chain reactions, relevant to the work in this dissertation, 
modify the sulfhydryl groups of cysteine residues (discussed in Chapter 5) and amino groups of 
lysine residues. Site-selective modifications targeting the amino group of lysine residues owe 
their success to the chemical properties of the nitrogen. Amine groups can be considered either 
primary, secondary, or tertiary, correlating to the number of covalently bound constituents, 1, 2, 
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or 3, respectively. The covalently bound constituents create polarizable bonds at the C-N and N-
R bonds, which are conjugated to the lone pair the nitrogen carries, resulting in the high 
susceptibility of the nitrogen to form hydrogen bonds. Due to the low electronegativity of 
nitrogen, the hydrogen bonds formed are slightly weaker than those formed with oxygen are. 
However, the lower electronegativity of nitrogen means that nitrogen is a good nucleophile, a 
trait most of the amino acids targeted for modifications possess. Thus, the majority of the side-
chain modification reactions proceed via a SN2 reaction pathway. The complexity of the 
protein’s structure is directly related to the diverse nature of the amino acid sequence. The 
nucleophilic character of the side chains is variable, ranging from the essentially unreactive 
amino acids to very nucleophilic. Aside from the nucleophilicity of the side chain, there are 
several other factors to consider when choosing a site-selective reaction. One factor being the 
frequency of amino acids in the protein sequence. Another factor to consider is the accessibility 
of the targeted amino acids to the solvent, being mindful of the hydrophobic character and 
possible interactions with neighboring amino acids, which may structurally influence or hinder 
modification.73-76  
1.6.1. Lysine Specific Modifications 
Lysine is a basic, polar residue with a positively charged epsilon amino group.77 There 
are a number of different reactions involving an array of reagents that can be used to achieve 
site-selective modification of lysine residues, including acylation, acetylation, and alkylation. 
Acylation of amine groups involves the addition of an acyl group, using an acid anhydride. This 
reaction results in the modification of the -amino group of lysine residues while the 
modification at the -amino group is often not achieved.78 A variety of different anhydrides is 
used to achieve this modification. For example, the use of citraconic acid as the acylating reagent 
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results in a reversible modification that is useful in the separation of the protein from nucleic 
acids.79-83 Another example is the use of succinic anhydride for acylation, where the modification 
showed promise in the solubilization of membrane proteins.84 One of the major limitations to 
using succinic anhydride is the reagent’s lack of specificity, as it will also modify other side 
chain moieties, such as sulfhydryl, phenols, and histidine.85-86 The use of acetic anhydride yields 
the addition of an acetyl group in a reaction known as acetylation. This reaction is one of the 
oldest chemical modification reactions and one of the most utilized reactions for amino acid 
modification.87 As a result, the reaction has found widespread use in the field of analytical 
chemistry, particularly with the advancement of mass spectrometry technology, where the 
modification has been used to study protein conformational changes, binding domains, and 
protein structure.88-90 The modification of lysine residues is also achieved by alkylation. Unlike 
acylation, this reaction is specific to lysine residues and is achieved with the use of both an 
alkylating reagent and a reducing reagent. This reaction was confirmed by several methods 
including 13C NMR and amino acid analysis.91-94 One of the most common alkylating reactions 
used to modify proteins is reductive methylation. 
1.6.2. Reductive Methylation  
The reductive methylation reaction, first presented in 1968, is a highly selective side 
chain modification reaction, which efficiently labels the amino of the lysine residue and the 
amino group of the N-terminus.91 The resultant modification retains the positive charge on the 
amino side chain maintaining its basicity and providing a near biological pH environment. The 
polar nature of the lysine side chains means that they are usually solvent exposed and located at 
or near the protein surface where they can participate in hydrophilic interactions and be easily 
modified.77 Typically, the reaction proceeds through several additions of the modifying reagents 
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over the course of several hours. More specifically, reductive methylation of proteins is achieved 
with the use of two reagents, a reducing reagent and a methylating reagent. The reaction 
proceeds through a dehydration step to yield the Schiff base intermediate that is then reduced to 




The monomethylated species has a higher pKa value than the unmodified species; thus, the 
methylating reagent readily converts the monomethylated species to the dimethylated species. 
This reaction is illustrated in Equation 1.2. 
 
To achieve reductive methylation, a number of different reagents were studied to determine the 
best modifiers. Typically, formaldehyde is the methylating reagent of choice as the use of other 
carbonyls either yields the monomethylated product and/or demonstrates lower overall 
conversion to the modified species resulting in longer reaction times.91, 96 There is an array of 
reducing reagents that are utilized in the reaction. Initially, sodium borohydride, NaBH4, was 
employed to achieve the modification. However, the need for extreme reaction conditions, such 






The use of sodium cyanoborohydride, NaBH3CN, posed a solution, addressing the 
limitations of the previous reagent by eliminating the need for the high pH demands of NaBH4, 
conditions that are not ideal for the majority of proteins, allowing the reaction to take place at 
physiological pH. Additionally, NaBH3CN does not participate in side reactions. Despite the 
reagent’s advantages, the use of NaBH3CN posed a problem as well due to the reagent’s 
susceptibility to produce cyanide ions. The cyanide ions produced by the reaction have the 
ability to react with the Schiff base intermediates, decreasing the degree of modification, by at 
least 20%.97-98 To address the unwanted production of cyanide ions, Rayment proposed in 1998, 
based on work previously done by Geoghegan and Cabacungan, a solution exploring the use of 
amine borane complexes as the reducing reagents in the reaction.  
Of the many amino borane complexes tested, dimethylamine borane complex, DMAB, 
was determined to have the best overall reactive qualities such as stability in water, reduction 
potential, and interaction of the protein and amine.99-101 Using DMAB and formaldehyde as the 
reducing and methylating reagents, respectively, will, depending on ratio of lysine to 
formaldehyde, result in complete modification.100 Following the modification reaction time, the 
reaction is quenched and dialyzed to remove any excess reagent. It is important to note that when 
formaldehyde is used as the methylating reagent, the reducing reagent must be added first, 
followed by the addition of the methylating reagent in order to minimize any cross-linking. This 
order is reversed if other aldehydes or ketones are used due to their decreased ability to achieve 
the modification.102 In addition, the use of DMAB as the reducing agent allows the reaction to be 
conducted at pH values between 7-10. Proteins modified by reductive methylation experience 
minimal chemical and physical changes as the addition of the modification maintains the positive 




Additionally, unless the modification occurs at an essential lysine residue, function is not 
hindered.103 Rypniewski also demonstrated that the modification yields a protein whose structure 
is very similar to the unmodified.104 Though reductive methylation found its initial use as a 
method to enhance protein crystallization for structural studies by x-ray crystallography, there 
are many other uses for this modification.  
1.7. Reductive Methylation as a Structural Probe 
While reductive methylation of proteins has been advantageous to the study of proteins 
overall, the scope of this dissertation is focused on its use as a method to probe protein structure. 
An early application of reductive methylation was its use as a method to improve the 
crystallization of proteins, enabling structure determination by x-ray crystallography.100, 105 The 
improvement in crystallization of the reductively methylated proteins has been linked to the 
protein’s increased ability to participate in more non-covalent interactions, reducing the surface 
entropy and yielding a more uniform pattern of crystallization.106  
A limitation of this method is that its success hinges on the ability to obtain a crystal, a 
task often difficult to achieve. An alternative to x-ray crystallography is nuclear magnetic 
resonance (NMR) spectroscopy, a method where structural studies are conducted in near 
biological environments. This technique allows for the observation of the dynamic behavior of 
proteins such as folding, structure formation, and protein interactions when in solution.107-111 The 
goal of this dissertation is to address the limitations of reductive methylation as it relates to the 
reaction’s applicability as a structural probe for NMR studies. In addition, a unique application 




1.7.1. Reductive Methylation as a Structural Probe for NMR and Efforts Towards the 
Assignment of the Resulting Dimethylamine Peaks  
 Since its introduction in 1968, reductive methylation has been used as a tool for studying 
proteins.112-113 As it relates to NMR studies, the methyl groups introduced by this labeling 
method are demonstrated structural probes, used to monitor an array of protein dynamics and 
properties such as protein-ligand interactions and the determination of the functional roles of the 
protein’s lysine residues.95, 114 However, there has been considerable difficulty in the 
establishment of a standard method for the assignment of the dimethylamine groups. This is 
important because as with any structural studies conducted by NMR, assignment of spectral 
peaks is necessary to interpret data. Since the introduction of the labeling method in 1968, 
several attempts were made towards the development of a reliable and accurate method for 
dimethylamine assignment. For example, Bradbury and Brown took advantage of the protein’s 
ability to bind gadolinium (Gd+3) and used reductively methylated hen egg white lysozyme to 
demonstrate a novel method for assigning dimethylamine NMR peaks.115 They monitored the 
effects on the spectra when the concentration of the cation was increased. Gd+3 is paramagnetic 
in nature and when placed in the magnetic field of the NMR, has a distance dependent 
broadening effect on NMR peaks. This effect is inversely proportional to the distance to the sixth 
power (1/r6) between the nucleus of interest and the paramagnetic ion. Thus, in the presence of 
Gd+3 nuclei less than 24 Å from the cation will experience peak broadening. Hen egg white 
lysozyme is comprised of six lysine residues and the N-terminal amino group giving the protein 
seven total reaction sites for modification by reductive methylation. Peak assignments of the 
seven dimethylamine peaks of hen egg white lysozyme was accomplished by comparing the 
changes in relative peak intensities with the distances from the protons of the dimethylamine 
groups to the metal, determined by the x-ray structural data. While this method successfully 
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demonstrated the utility of the method for residue assignment, it relied on both the ability of the 
protein to bind a paramagnetic metal ion and on x-ray structural data. Two years later, in 1975, 
Bradbury and Brown demonstrated a modified dimethylamine peak assignment method using 
Ribonuclease A (RNAse A) by conducting titration studies. Using this method, they were able to 
make partial assignments based on the distinct pKa values of the - and -dimethylamino groups. 
In addition, they were able to identify dimethylamines involved in the formation of salt bridges. 
The pKa of an -dimethylamino group is in the range of 9.5 – 11.0, depending on the 
environmental surroundings. The pKa of a -dimethylamine group is usually around 7.0. When 
the amine is involved in the formation of a salt bridge, the pKa is markedly lower.
116 They were 
able to assign the amino group, which had a pKa value of 6.6. In addition, they were able to 
assign the -amino groups of Lys4, which had a pKa value of 8.6. This result was corroborated 
by the x-ray crystal-structure data, suggesting that the residue participates in the formation of a 
salt bridge. The resulting partial assignments from this method relied heavily on crystal structure 
data and titration data that alone proved to be insufficient for the assignment of the remaining 
dimethylamines as their pKa values fell within the range of 10.6 – 11.2. 
 Jentoft and Dearborn presented the utility of reductive methylation in 13C NMR studies in 
1979, when they presented an improved labeling method using NaBH3CN as the reducing 
reagent, increasing the labeling efficiency of the reaction. In addition, their method demonstrated 
the use of 13C labeled formaldehyde as the methylating reagent. Using the 13C labeled 
formaldehyde allowed for the observation of both the dimethylamine and monomethylamine 
peaks using 13C NMR, which is not easily achieved using solely 1H NMR due to substantial peak 
overlap.98,117  13C NMR allows one to distinguish the order of the labeled peaks by their chemical 
shifts, with monomethylamines having chemical shifts between 32-34 ppm and dimethylamines 
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having chemical shifts in the range 41-44 ppm. This work demonstrated that the variation of the 
molar ratio of formaldehyde to the lysine residues of the protein has a direct influence on the 
degree of modification. They were able to make peak assignments by spectral comparison of 
RNase A to model compounds and easily identified the  and -dimethylamine peaks by pH 
titration due to their characteristic shifts either up or downfield with increasing pH. Subsequent 
works utilized Jentoft and Dearborn’s improved labeling methods, but differ by the assignment 
method used. In 1982, Gerken et al. published work using Jentoft and Dearborn’s reductive 
methylation method in conjunction with the x-ray crystal structure to make and confirm accurate 
peak assignments of hen egg white lysozyme.92  They also made assignments of the N-terminal 
and -dimethylamine peaks using titration curve behavior and pKa values. However, this 
method was not sufficient for complete peak assignments. Other similar methods used predicted 
structures rather than the crystal structure to make assignments.118  
Another important advance was the introduction of partial labeling. Pioneered by Dick 
and coworkers in 1988, the method resulted in partial assignments using their knowledge of the 
binding properties of the fd gene 5 protein (G5P).119 Upon binding, some of the lysine residues 
of this particular protein are structurally protected from the reductive methylation reaction. 
Labeling was achieved by two subsequent reductive methylation reactions. The first reaction 
introduces 13C methyl groups to the protein, as it was wound to the ligand.. This reaction was 
followed by a second methylation of the unbound protein, introducing 14C methyl groups as 
radio labels.94 Digestion of the protein followed by Edman degradation for sequencing allowed 
for measurement of the radioactivity of the cleaved amino acids. The extent of labeling of the 
cleaved amino acids indicated the degree of residue protection upon ligand binding. Those 
residues, which were more protected had a higher incorporation of the radiolabel and exhibited 
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less intense 13C NMR peaks. The degeneracy of the 14C labeling resulted in a group-wise 
assignment of the -amino groups while the use of carboxypeptidase B, a C-terminal cleaving 
enzyme, aided in the determination of the C-terminal lysine. In addition, differences in 13C NMR 
spectra of the fully labeled and the partially labeled samples allowed for the identification of the 
protected lysine residues, which lie at the binding interface.  
For NMR studies, a desired characteristic of a residue assignment method is that it does 
not require prior knowledge of the protein structure, aside from the amino acid sequence. Such a 
method was presented by Zhang and Vogel using two dimensional (2D) NMR. Their work was a 
notable advancement in the progression of residue assignment methods. The addition of the 
second dimension improved upon the signal dispersion of the dimethylamine peaks in both the 
carbon and proton dimensions. In their work, they expressed mutants of the protein calmodulin 
using site directed mutagenesis. This created 7 different mutants in which a single lysine residue 
of the protein had been mutated to a glutamate residue. Each mutant was reductively methylated 
and the 13C methyl groups were observed using 2D 1H-13C heteronuclear multiple quantum 
coherence (HMQC) NMR experiments.120 A comparison of the reductively methylated spectrum 
of the native structure to a spectrum of a mutant allowed for the residue assignments. This 
assignment was possible because residues modified from a lysine to glutamate were not modified 
by reductive methylation and therefore would not be observed in the spectrum. This work is 
noteworthy as it presents a method that was able to not only achieve complete assignment of the 
lysine residues by 2D NMR, but did so without prior knowledge of the protein structure. This 
method is most suitable for proteins with a modest number of lysine residues as the site-directed 
mutagenesis of a protein is labor intensive. 
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In 2000, Ashfield and coworkers contributed a notable advancement in the development of 
NMR residue assignment methods. Their work used 2D NMR and mass spectrometry as 
complementary techniques for residue assignment. In their study, they reductively methylated 
human MIP-1 D26A (hMIP-1protein whose structure is comprised of three lysine residues. 
The resultant 13C dimethylamine groups were observed in both one dimensional (1D) and two 
dimensional (2D) 1H-13C heteronuclear single quantum coherence (HSQC) spectra. The 
disappearance of peaks in the spectra were compared to the disappearance of the modified tryptic 
peptide masses in the matrix assisted laser desorption ionization- time of flight (MALDI-TOF) 
spectra. Their experiments accomplished several things, the first of which was that they allowed 
them to discover that the structure of this protein was concentration dependent, and that at high 
concentrations, one lysine residue was buried in the globular structure of the protein and was 
thus protected from reductive methylation. Secondly, their technique allowed for the absolute 
assignment of the lysine residues of the protein, establishing a method that did not rely on prior 
knowledge of the protein structure. A third accomplishment is that the use of MS eliminated the 
need for radiolabeling and Edman degradation as the change in mass observed in the mass 
spectrum indicated modification.121  
The combination of partial labeling, isotopic labeling by reductive methylation, 2D 
NMR, and MALDI-TOF mass spectrometry (MS) gave rise to the work published by 
Macnaughtan and coworkers in 2005, where they proposed a novel residue assignment 
method.122 Using hen egg white lysozyme as a model protein, the protein was partially labeled 
by reductive methylation using DMAB and 13C labeled formaldehyde as the reducing and 
methylating reagents, respectively. The first methylation reaction was followed by a second 
reaction where the methylating reagent used was natural abundance formaldehyde to complete 
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dimethylation of the samples. The intact protein samples were analyzed by 2D 1H-13C HSQC 
NMR experiments, and the peak volumes of the 13C dimethylamine peaks in the NMR were 
measured to calculate the percent methylation at each residue. The reductively methylated 
protein was then digested by trypsin to determine the mass shift in the isotopic profiles of the 
mass spectrum to determine the percent methylation of the residue. In addition, the identity of 
the modified lysine can be determined by the mass of the peptides, which is unique given the 
method of cleavage of the enzyme. Residue assignment was achieved by the comparison of 
values of modification obtained from the NMR and MS data. Only three of the seven reaction 
sites were definitively assigned in this study, and the remaining four NMR peaks were assigned 
in a pair-wise fashion. This method, while novel in its utility, was still unsuccessful in the 
determination of signals belonging to adjacent reaction sites such as Lys96 and Lys97 and 
Lys1 and Lys (N-terminus). The partial peak assignments achieved using this method were 
largely due to the degenerative labeling of the lysine residues. Degenerative labeling of the 
lysine residues is sometimes encountered when using reductive methylation and is a result of 
similar levels of incorporation of the methyl groups.  
 A recent study published in 2013 by Larda and coworkers details a residue assignment 
method that highlights a protocol to preferentially produce the monomethylated product of 
reductive methylation, asserting that this method improved peak resolution and exchange 
broadening.123 In addition, they explored the incorporation of deuterium tags, allowing the 
filtering of the natural abundance 13C signals using different NMR pulse sequences for 13C-1H 
experiments. Peak assignments were accomplished through the comparison of the assignments 
made by Macnaughtan, the x-ray crystal structure, the aromatic nuclear Overhauser effects 
(NOEs), and line broadening effects of dissolved nitroxide labels. Though this method did 
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achieve absolute assignment of the monomethylated NMR peaks, the assignment success of this 
method relied heavily on the data from previous work and the x-ray crystal structure.  
1.8. Dissertation Scope  
The substantial work highlighting the use of reductive methylation as a structural probe 
for NMR studies over the past forty years affirms the importance of this reaction for protein 
research. The work detailed in the remaining chapters is focused on novel applications of the 
reaction for protein research, while also addressing some of the limitations of the labeling 
method. Chapter 2 of this dissertation details and discusses a project, which expands upon work 
published by Macnaughtan and coworkers in 2005 by addressing the issue of degenerate labeling 
of reductively methylated protein through the introduction of various solid phase media into the 
reaction mixture. The media is introduced to mimic biological structural protection of lysine 
residues that has been shown to inhibit reductive methylation. The overall goal of this method is 
to increase the variation in the extent of labeling of the reaction sites to break the labeling 
degeneracy. Chapter 3 details and discusses a project addressing the issues of peak resolution 
and intensity, which prove to be problematic during the process of peak fitting. This work 
identifies methods to increase the resolution of the dimethylamine peaks by varying both 
temperature and pH as well as titration studies with EDTA and cobalt. The overall goal of this 
project is to identify methods to aid in achieving more accurate peak fitting to yield more 
definitive peak assignments. In the area of protein research, protein quantitation is a necessary 
step. Colorimetric protein assays are readily and routinely used because they are rapid and 
sensitive. Due to the reliance of researchers on the accurate determination of protein 
concentration, Chapter 4 details and discusses an investigation on the variation in the 
quantitation of unmodified versus reductively methylated proteins using the Bradford and 
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bicinchoninic acid (BCA) assays. An example of how reductive methylation is used as a 
structural probe for the elucidation of protein structure is detailed and discussed in Chapter 5. 
The overall objective of this project is the development of a method to determine the structure of 
a protein-protein complex formed by a cysteine protease and a cysteine protease inhibitor (ICP). 
Both of the proteins are chemically modified: ICP is modified with a nitroxide spin label, and 
papain is modified by reductive methylation. Upon binding in solution, the nitroxide spin label 
induces paramagnetic relaxation enhancement (PRE) of the 13C dimethylamine signals of papain. 
Given that the PRE effects of the spin label are distance dependent, data from PRE-NMR studies 
can be used to determine distance restraints. 
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ADDRESSING DEGENERATE LABELING BY REDUCTIVE METHYLATION WITH 
THE USE OF SOLID PHASE MEDIA FOR THE ASSIGNMENT OF 
DIMETHYLAMINE NMR PEAKS 
2.1. Introduction 
The study of protein structure allows for the comprehensive understanding of the function 
of proteins. This knowledge aides the development of technologies that can not only assist in 
curing diseases, but can also help in finding active and preventative treatment solutions.2-5 The 
two most readily used methods for protein structure determination are x-ray crystallography and 
nuclear magnetic resonance (NMR) spectroscopy. Structural studies by x-ray crystallography 
require protein crystallization; however, crystal formation is not always easily accomplished and 
can be a limiting factor. Another limitation of x-ray crystallographic structure determination is 
that it does not account for the dynamic nature of protein structure and thus lacks the ability to 
monitor the dynamic behaviors of the protein. In addition, the crystal structure formed is not 
always the dominant structure of the protein.6 Conversely, protein structural studies by NMR 
spectroscopy allow for the sample to be studied in near biological environments where dynamic 
behaviors such as binding and folding, can be observed. Structure determination by NMR is a 
meticulous process involving several steps, which include protein labeling, data acquisition, and 
data interpretation.7 The first step in data interpretation is the process of peak assignment, which 
relies on the introduction of structural probes by isotopic labeling. Peak assignment is integral to 
structure determination because complex data interpretation is not possible without first 
assigning the observed peaks in the spectrum. Thus, we will first discuss the topic of isotopic 





2.1.1. Isotopic Labeling of Proteins for NMR 
The isotopic labeling of proteins is an integral portion of biological studies by NMR, by 
which the dynamics of the molecular interactions of proteins can be observed on time scales that 
allow for atomic level structure determination to be achieved.8 Since the late 1960s, when the 
first experiments involving isotopically labeled proteins were conducted, there have been 
significant advancements in both labeling methodologies and in the technology of NMR.9-11 
Nuclei with an odd number of protons and/or neutrons possess a non-zero spin, giving them 
magnetic moments. The intrinsic magnetism of the nuclei causes them to behave as small 
magnets when placed in an external magnetic field. The magnetism of the external field causes 
the magnetic spins of the nuclei to either align parallel or antiparallel to the external field. Spins, 
which align parallel to the external field, are considered to be in the low energy state, and those, 
which align antiparallel to the external field, are considered to be in the high energy state. The 
transition of spins from the low energy state to the high energy state during energy absorption 
and the transition of the spins back to low energy during emission produces the observed NMR 
signals.12  
The most abundant and sensitive isotope used for NMR studies is 1H, which has a natural 
abundance of approximately 99.985%. However, structural studies using this isotope are most 
effective with smaller proteins. For larger proteins, the resulting spectral peaks are oftentimes so 
overlapped that peak assignment is difficult.13 Other naturally occurring isotopes useful for NMR 
studies are 13C and 15N, but these isotopes have much lower natural abundances, 1.1% and 
0.37%, respectively. Isotopic labeling by 13C and 15N can be accomplished during protein 
expression by growing the bacteria in minimal media supplemented with 13C glucose and 15N 
ammonium chloride, which is then incorporated into the expressed protein.9, 14-15 However, this 
37 
 
complete labeling method is not amendable to proteins that do not express well in bacterial hosts. 
An alternative method for isotopic labeling is through the introduction of chemical labels at 
specific amino acids. Chemical modification methods are advantageous in that they allow for the 
direct observation of the behavior of specific amino acids of a protein. Isotopic labeling through 
this approach can also help make peak assignments easier with fewer peaks to assign. Reductive 
methylation is one such alternative, which results in the addition of methyl groups at the -amino 
group of lysine residues and the -amino group of the N-terminus. By using 13C labeled 
formaldehyde as a methylating reagent, 13C labeled methyl groups can be incorporated into the 
protein. In addition to the methylating reagent, a reducing reagent such as dimethylamine borane 
complex (DMAB) is necessary for modification. The resulting 13C labeled dimethyl groups allow 
for the utility of 13C NMR and act as structural probes.16-17 Isotopic labeling by reductive 
methylation will be the primary protein labeling method used in this work. 
2.1.2. Previous Peak Assignments of Reductively Methylated Proteins 
Not only is peak assignment the first step in data interpretation for structural studies, it is 
the most critical in that accurate assignments allow for more definitive behavioral observations 
from the spectra acquired. In the absence of accurate assignments, the signals of the spectra are 
meaningless for structure determinations. In regard to peak assignment of reductively methylated 
proteins, there has been considerable effort to this end. While some methods experienced more 
success than others, no single technique has been established than can be used as a general 
protocol for peak assignment. The work detailed in this chapter uses hen egg white lysozyme as 
a model protein. Thus, the discussion below of previous assignment methods is limited to those 
which used reductively methylated hen egg white lysozyme in the assignment of the 
dimethylamine NMR peaks. As previously discussed in Section 1.6.1. of Chapter 1, there have 
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been several works published, which presented peak assignment methods using hen egg white 
lysozyme. Of these methods, few have been presented that do not rely heavily on structural data 
or pH titrations. Such methods are not ideal for proteins whose structure has not been solved.  
Hen egg white lysozyme is an enzyme, which is found abundantly in egg whites, 
characterized by its ability to hydrolyze the polysaccharide matrix of bacterial cell walls and 
thought to act as an antibiotic agent.18 Structurally, it comprises a single polypeptide chain that is 
129 residues in length. Within the amino acid sequence, there are 6 lysine residues (Lys1, 
Lys13, Lys33, Lys96, Lys97, and Lys116) and the N-terminus (Lys1), giving the protein 
seven total reaction sites for reductive methylation. Table 2.1. lists the assignments of the 
dimethylamine peaks of hen egg white lysozyme published previously. While there is 
considerable overlap of some of the assignments presented in the table, the only assignments that 
are definitive and supported by significant data are the assignments of peaks 6 and 7 assigned to 
Lys1 and Lys1, respectively. Bradbury and Brown made the first assignments of reductively 
methylated hen egg white lysozyme using proton NMR. To make assignments, they determined 
the pKa value of each of the -dimethylamine groups by pH titrations, which they compared to 
pKa values obtained from titrations of model compounds. In addition, they used the crystal 
structure distances from the assumed binding site of the cation gadolinium (Gd+3), which occurs 
between Glu35 and Asn52, to the sites of methylation and compared them to the distances 
calculated from the changes in peak intensity as the concentration of Gd+3 was increased. The 
observed changes in peak intensity were due to the paramagnetic nature of the cation, which has 
a distance dependent effect on the NMR peak that is inversely proportional to the distance from 
the cation to the methyl group (1/r6). Peak 7 was assigned to the -amino group by the process of 
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elimination following assignment of the -amines as only 6 peaks were visible in the proton 
spectra due to poor labeling of the -amine reaction site.   









Roberson et al.22  Larda et. 
al23 
1 Lys97 ~Lys97 Lys1 or  Lys13 Lys13 Lys13





3 Lys116 Lys13 Lys1 or Lys13 Lys97 Lys96
4 Lys13 Lys97 Lys1 Lys96 Lys97





6 Lys1 Lys1 Lys96 Lys1 Lys1
7 Lys1 Lys1 Lys97 Lys1 Lys1
 
Gerken et al. also presented an assignment method for reductively methylated hen egg 
white lysozyme using distinct pKa values and x-ray structural data to make assignments. Distinct 
pKa values of the N-terminal -amino group, identified in a later work by Brown and Bradbury, 
lead to the assignment of Lys to peak 7.24 The ion pairing of Lys1 with Glu7 resulted in the 
assignment of Lys1 to peak 6 due to a pKa value that falls below the typical range of -
dimethylamines.20 In addition to the peak assignments made for Lys1 and Lys1, this method 
allowed for the assignment of Lys13 by using structural data, which suggested that the amino 
acid participated in a salt bridge with the C-terminal residue, Leu129. This salt bridge results in a 
pKa value that falls below the typical range of values for -amino groups. To confirm that this 
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interaction occurs, an enzyme was used to cleave the C-terminus to disrupt the salt bridge 
formation, resulting in a pKa increase for Lys13.  A tentative assignment for Lys97 to either 
peak 1 or peak 4 was also made. The remaining residues could not be assigned with this method. 
The assignments published by Macnaughtan et al. varied the most from the other 
methods; however it is the first method to make assignments without the reliance on previous 
structural knowledge of the protein, aside from the amino acid sequence.21 As discussed in 
Section 1.6.1 of Chapter 1, this method expanded upon the work published by Fischer et al., 
which combined two dimensional (2D) NMR spectroscopy and MALDI MS using 
substoichiometric labeling.25 Percent 13C methylation values of each NMR peak and each lysine 
containing tryptic peptide were compared and peak assignments were made based on similar 
values. This method resulted in three definitive peak assignments while the remaining four peaks 
were assigned in a pairwise manner. The pairwise assignments were a result of degenerate 
labeling encountered when using reductive methylation. The labeling degeneracy encountered 
can be attributed to similar environments of the reaction sites, resulting in similar levels of 
incorporation of 13C-methyl groups.  
The method published by Roberson et al. was an extension on Macnaughtan’s method 
with the distinction of being able to identify the peaks in the spectrum belonging to the Lys1 
and Lys1.22 These reaction sites are problematic for assignment because the signal for both 
arises from a single residue, Roberson and co-workers were able to make definitive assignments 
of the Lys1 and Lys1 residue peaks using two methods. The first method used an N-terminal 
cleaving enzyme, aminopeptidase, to cleave the first three amino acids. This cleavage was 
confirmed by both MS and NMR. A second method used to distinguish the two signals was 
achieved by varying the pH of the reductive methylation reaction, conducting the reaction at pH 
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10.0 and pH 6.0. Varying the pH during the reaction affects the reaction’s labeling efficiency at 
the Lys1 and Lys1 reaction sites. At pH 10.0, Lys1 is modified with decreased efficiency. 
Conversely, when the reaction takes place at pH 6.0, the labeling of Lys1 is increased 
significantly and exhibits the most intense peak in the spectrum. The remaining five residues 
were assigned using the assignment method published by Macnaughtan et al. A method 
published by Larda et al. also achieved definitive assignment of Lys1 and Lys1. Their 
assignment method differs from the previous methods in that the assignments were achieved 
using monomethylamines.23 In addition, their assignments heavily relied on the corroboration of 
the data from the work published by Macnaughtan and coworkers, x-ray crystal structure data, 
and the line broadening effects of a dissolved spin label.  
The aforementioned assignment methods have thus far only been able to definitively 
assign two of the seven dimethylamine peaks. In addition, the methods presented (Brown and 
Bradbury, Gerken et al., and Larda et al.) all relied heavily on structural data to make 
assignments. The methods presented by Macnaughtan et al. and Roberson et al. addressed this 
issue by presenting methods which do not rely on such data. However, the pairwise nature of the 
assignments made by Macnaughtan et al. highlights a limitation to the labeling method for peak 
assignments. Thus, there is still a need for an assignment method to break the degeneracy 
encountered using reductive methylation and allow for the definitive assignment of all the 
dimethyllysine residues of the protein. Efforts toward this end are detailed in the remainder of 
this chapter. 
2.1.3. Towards Breaking the Degeneracy of Reductive Methylation with the Introduction of 
Solid Phase Chromatographic Media 
 
Though reductive methylation is an established method used for isotopically labeling 
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the G-series of Sephadex also is characterized by its interaction with the aromatic amino acids of 
the protein.28-29 A third medium used, Lipophilic Sephadex (LH-20), also falls into the Sephadex 
family and is a derivative of the G-series. It is prepared by hydroxypropylation of the G-25 
Sephadex, yielding a polysaccharide matrix with the structure shown in Figure 2.4. Lipophilic 
Figure 2.3. Partial structure of Sephadex.
Figure 2.4. Partial structure of Lipophilic Sephadex. 
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Sephadex is characterized by its dual hydrophilic and lipophilic character. Like the G-series, 
Lipophilic Sephadex is also used for gel filtration, but is typically used for the separation of 
natural products like lipids and low molecular weight peptides.30 The fourth medium that was 
used was C18 silica. This medium is generally used for reversed phase chromatography, which is 
characterized by a hydrophobic stationary phase. The hydrophobic nature of the medium will 
interact with the hydrophobic areas of the surface proteins.31 The structure is illustrated in Figure 
2.5. 
 
 To increase the variability of the labeling at each reaction site, the protein was labeled 
using substoichiometric ratios of 13C methyl groups by using limiting amounts of 13C labeled 
formaldehyde as the methylating reagent. The schematic illustrating this labeling method is 
illustrated in Figure 2.6. Labeling the protein in this manner exploits the reaction rate of each 
reaction site. Upon reaction with substoichiometric ratios of the reducing and methylating 
reagents, 13C methyl groups will be incorporated at different rates at each of the reaction sites. 
Sites where incorporation of the methyl groups is fast (denoted in green) will be completely 
dimethylated with 13C methyl groups. Other sites, where incorporation is moderate, will only be 
partially labeled (denoted in yellow), while sites which incorporate the 13C methyl groups the 
slowest (denoted in red) would have very low levels of 13C methyl groups by reductive 
methylation. Following the incorporation of the 13C methyl groups, dimethylation of all reaction 
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degeneracy and allow for more accurate and definitive assignments of dimethylamine peaks. 
Additionally, the proposed method does not require prior knowledge of protein structure, aside 
from the sequence.  
2.2. Methods and Materials 
2.2.1. Protein Preparation and Reductive Methylation of Hen Egg White Lysozyme  
Fresh stock solutions of hen egg white lysozyme were prepared at a concentration of 5 
mg/mL in 100 mM potassium phosphate buffer (K+PO4
-3) at pH 7.5 (reaction buffer). All 
samples were reacted in 15 mL conical tubes. For samples to be reductively methylated in the 
presence of media, 50 mg of media was added to each tube. Before the addition of protein to 
Lipophilic Sephadex and G-15 Sephadex, the media were washed three times using 250 L 
aliquots of the reaction buffer in order to wet the media. With each addition of reaction buffer, 
the media was vortexed and then centrifuged at 1000 x g for 2 minutes. Following centrifugation, 
the supernatant was removed prior to the addition of the second and third wash aliquot. 
Immediately following the removal of the supernatant of the third wash, 250 L aliquots of the 
protein stock were added to the media, forming a slurry. For samples labeled in the presence of 
G-75 Sephadex, the wash step was omitted due to the difficulty of separating the supernatant 
from the media. This is most likely due to the lower degree of crosslinking of the G-75 Sephadex 
in comparison to the G-15 Sephadex, enhancing its ability to swell due to less rigidity of the bead 
structure when compared to G-15 Sephadex. Samples labeled in the presence of C18 media are 
an additional exception as the media was first wetted with methanol before the addition of 
protein due to the difference in polarity between the buffer solution and the media.  
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After vortexing, all samples, including the negative controls, were incubated at room 
temperature for one hour undisturbed in order to allow the protein and the media to interact. 
Control samples contained a 250 L aliquot of the stock protein solution and no media. Stock 
solutions of the reducing reagent, dimethylamine borane complex (DMAB, Sigma), and the 
methylating reagent, natural abundance formaldehyde (Sigma) or 13C labeled formaldehyde 
(Cambridge Isotope Laboratories), were prepared fresh in Millipore water and kept on ice at a 
concentration of 153 mM. Four samples each of the control and media-containing samples were 
prepared for the reaction of the protein at different concentrations of formaldehyde: 1.2 mM, 2.5 
mM, 4.9 mM, and 9.8 mM. These concentrations correspond to the molar ratio of formaldehyde 
to lysines of 1:0.5, 1:1, 1:2, and 1:4, respectively. The concentration of the reducing reagent used 
for each sample was equivalent to half the concentration of the formaldehyde used for the 
respective sample. To complete the reductive methylation, an aliquot of DMAB was added to a 
sample, and the sample was then gently vortexed before the subsequent addition of 
formaldehyde. The addition of the reagents in this order minimizes crosslinking and other side 
reactions of formaldehyde.32 
Following the addition of formaldehyde, each sample was vortexed and wrapped in foil 
for incubation at 4 °C for two hours while shaking. After two hours, the addition of DMAB and 
formaldehyde was repeated, followed by vortexing and incubation for an additional two hours. A 
final aliquot of DMAB was added to all samples at a concentration equivalent to half the 
previous additions. All samples were vortexed and incubated overnight for a total reaction time 
of 24 hrs. At the end of the reaction period, an aliquot equivalent to 12.2 mM ammonium sulfate 
(Sigma), from a 153 mM stock prepared fresh in Millipore water, was added to each sample to 
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quench the reaction. Following the addition of ammonium sulfate, the reaction was incubated for 
an additional hour.  
2.2.2. Separation of Media from Reductively Methylated Proteins 
Following reaction quenching, the chromatographic media was separated from the 
reductively methylated samples using spin cups (Pierce) and by three 200 L aliquots of 99% 
acetonitrile (ACN), 1% trifluoroacetic acid (TFA), both purchased from Sigma. Following each 
addition, the media was centrifuged at 800 x g for one minute. Control samples were kept in 
buffer from the reaction. All samples were dried and reconstituted in 200 L of Millipore water 
in preparation for MALDI MS analysis. 
2.2.3. Sample Preparation for MALDI MS Analysis 
In preparation for analysis by MALDI MS, all samples were desalted using C18 spin 
columns (Thermo). Desalting was achieved using the standard protocol published by the 
manufacturer using 30 g of protein for the binding step. Samples were eluted using 20 L of 
70% ACN, 0.5% TFA. See Appendix I for the full desalting protocol. In preparation for MALDI 
MS analysis of tryptic peptides, reductively methylated hen egg white lysozyme samples were 
combined with an aliquot of trypsin at a concentration equivalent to 1:20 trypsin to protein ratio. 
Trypsin-treated samples were incubated for 16-24 hours at 37 °C. After incubation, all samples 
were desalted using C18 spin columns as described in Appendix I. Dr. Michelle Sweeney 





2.2.4. Analysis by MALDI MS 
 For MALDI MS analysis, equal volumes of protein and a saturated sinapinic acid 
(Sigma) solution in 30% ACN, 0.1% TFA were mixed on a MALDI Target (MTP 384, Bruker) 
and allowed to dry under ambient conditions. Some samples were spotted on the plate with the 
addition of a myoglobin co-spot. Samples were analyzed using a Bruker UltraFlextreme in linear 
mode using a mass to charge (m/z) range of 5000 – 20000. A 355 Nd: YAG laser was used at 80-
90%, and 2000 laser shots were collected for each spectrum. Prior to sample analysis, the 
instrument was calibrated using Calibration Standard I (Bruker), prepared according to the 
manufacturer’s instructions. Bruker FlexAnalysis software was used to correct the baseline, 
smooth the data, and to manually select the peak apex for each sample. Data was smoothed using 
the Savitzky-Golay smoothing algorithm (1 cycle, 5 m/z). The percent methylation of each 
spectrum of the intact protein was determined. For samples spotted without a co-spot, the percent 
methylation was determined by the difference between the observed signal and the unmodified 
average mass of the protein plus a proton [M+ H+], which is equivalent to 14314.3 Da. This 
difference was then divided by the theoretical value of a hundred percent methylation of the 
protein using natural abundance formaldehyde (196.4 Da) or 13C labeled formaldehyde as the 
methylating reagent (210.3 Da). When samples were spotted with a co-spot, the percent 
methylation was calculated by first determining the difference between the theoretical mass of 
myoglobin [M+H+] to the experimental value. This difference was subtracted from the 
experimental signal of the modified hen egg white lysozyme, to give a corrected peak value of 
lysozyme. This corrected peak value was divided by the theoretical value of a hundred percent 
methylation of the respective methylating reagent. To calculate the percent methylation of each 
-amino group and the -amino group of the N-terminus, reductively methylated hen egg white 
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lysozyme was digested using trypsin, generating tryptic peptides. To identify lysine containing 
peptides, experimental data was compared to a theoretical peak list of the protein digested using 
trypsin. Experimental peaks which corresponded to theoretical peaks in the trypsin digested 
protein were further analyzed by MS/MS for identity confirmation. Since each sample is labeled 
using both 13C labeled and natural abundance formaldehyde, sample peaks contain a mixture of 
the two labels. Thus, comparison of the experimental and theoretical mass lists for samples 
labeled with 9.8 mM formaldehyde (also referred to as fully labeled samples) using both natural 
abundance and 13C labeled were conducted. For each confirmed fragment, the peak intensity was 
normalized and the average weighted peak intensity was calculated. The weighted average peak 
intensity indicates where the 13C labeling falls with respect to the fully labeled samples. The 
percent 13C labeling is calculated as shown in Equation 2.1, where A represents the weighted 
average peak intensity of the experimental data, B is the weighted average peak intensity for 
samples labeled with 9.8 mM 13C labeled formaldehyde, C is the weighted average peak intensity 
for samples labeled with 9.8 mM natural abundance formaldehyde, and D is the percent 12C 
labeling. The 13C percent methylation was calculated as given by Equation 2.2, by subtracting 
the calculated 12C labeling from 100. Dr. Michelle Sweeney did the analysis of the tryptic 
peptides. 
Percent 12C labeling = D =  [(∆ )]  
Equation 2.1. 
 




2.2.5. Reductive Methylation for Substoichiometric Isotopic 13C Labeling Experiments 
To achieve substoichiometric labeling, samples were first methylated using 2.5 mM 13C 
formaldehyde as the methylating reagent. Compared to the experiments detailed in Section 2.2.1, 
these reactions were scaled up by a factor of two, doubling the amount of media, protein, and 
reagent volumes, taken from stock solutions made at the same concentrations. Following reaction 
quenching, the samples were separated from the media as described in Section 2.2.2. A small 
amount of the reconstituted protein was desalted for MALDI MS analysis, as described in 
Section 2.2.3. The remainder of each sample was dialyzed against reaction buffer using Amicon 
centrifugal filter tubes with a molecular weight (MW) cutoff of 3000 Da, to a final volume of 
approximately 500 L. This volume was used for a second reductive methylation reaction where 
natural abundance formaldehyde was used as the methylating reagent at a concentration of 9.8 
mM to complete the dimethylation. Controls for these experiments were methylated using 9.8 
mM and 4.9 mM 13C formaldehyde in the absence of media followed by a reaction with 9.8 mM 
natural abundance formaldehyde. Spectra for these samples are shown in Appendix I in Figures 
A.1.1. – A.1.132. and Figures A.1.145 – A.1.156.  
2.2.6. Preparation and Analysis of Samples for Heteronuclear Single Quantum Coherence 
(HSQC) NMR  
Following the overnight incubation of the second reductive methylation reaction, samples 
were prepared for NMR analysis by dialysis using 3 kDa molecular weight (MW) limit Amicon 
Spin filters into reaction buffer in D2O (Cambridge Isotope Laboratories) at pH 8.5. A 1D 
1H-13C 
HSQC spectrum was acquired for each sample on a 700 MHz NMR using a relaxation delay of 5 
seconds and 256 scans at 25 °C. Spectra from these experiments are shown in Appendix I in 
Figures A.1.133 – A.1.144. 
53 
 
2.2.7. Calculation of Percent Methylation at Each NMR Peak 
 MATHCAD software was used to determine the area of each NMR peak using Equation 
2.3, where the variable C0 defines the baseline of the data, C1 defines the Lorentzian fraction of 
the peak, C2 defines the frequency of the peak in arbitrary units (Hz), C3 defines the Lorentzian 
line width, C4 defines the Gaussian line width, C5 defines the amplitude of the peak,  are the 
frequency values of the x-coordinate data in Hz, and n represents the number of peaks being fit. 
This equation generates a picture similar to that shown in Figure 2.7., where the red line 
represents the experimental data and the blue line is the fit line, which is initially adjusted to fit 
the experimental data set by changing the C0-C5 values. The manipulation of the values of C0-C5 
visually changes the line shape of the fit data (blue dotted line) to the experimental data (red 
line), and results in the determination of the initial values of the matrix (C) for the calculation of 
the peak area. Once the best visual fit has been achieved, a series of iterations are done for matrix 
C to minimize the error, defined by Equation 2.4., where the variable X defines the length of the 
data set and j is an index for each frequency in the data set. This calculation results in a matrix 
with the optimized values for the best fit of the experimental data. The fit (top) and peak area 
(bottom) equations are shown in Equation 2.5. The optimized matrix of C0-C5 values for peak 
fits can then replace the initial matrix to repeat the calculation until the error reaches a minimum. 
 
Equation 2.3. 
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(A), with the assumption that the labeling at each peak is proportional despite the lower 
concentration of modifying reagents. For each sample, normalized peak areas were summed to 
give, C. A concentration correction factor was then calculated when the percent methylation 
determined by MALDI MS was multiplied by seven (which is the number of spectral peaks) and 
then divided by C (the sum of the normalized peak areas), to give D, the corrected concentration 
factor. The percent 13C methylation of each peak was then determined by the product of the 
normalized peak areas, B, and the corrected concentration factor, D. 
2.3. Results and Discussion 
2.3.1 Reductive Methylation of Hen Egg White Lysozyme Using Increasing Concentrations 
of Formaldehyde in the Presence of Lipophilic Sephadex and G-15 Sephadex 
As proof of concept, hen egg white lysozyme was reductively methylated in the presence 
of chromatographic media in order to demonstrate the effects of the media on the labeling 
efficiency of the reductive methylation reaction. The samples for the experiment illustrated in 
Figure 2.8 used natural abundance formaldehyde as the methylating reagent. The graph shows 
the average percent methylation of the samples from the five replicates of the intact protein as 
determined by MALDI MS. For each trial hen egg white lysozyme was reductively methylated 
using increasing concentrations of natural abundance formaldehyde: 1.2 mM, 2.5 mM, 4.9 mM, 
and 9.8 mM. The percent methylation was calculated using the theoretical average mass of 
lysozyme [M+H+]. The results in Figure 2.8 show the steady increase of labeling percentage for 
all samples as the concentration of methylating reagent is increased.  
Samples that were reductively methylated in the presence of Lipophilic Sephadex and G-
15 Sephadex both exhibited lower labeling in comparison to samples labeled in the absence of 
media. Samples labeled in the presence of G-15 Sephadex had higher labeling than those labeled 
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in the presence of Lipophilic Sephadex. This result is most likely due to the increased interaction 
between the protein and the media at or near the sites of reductive methylation The increased 
interaction between the protein and the media can be attributed to the inherent hydrophilic 
character of the Lipophilic Sephadex media, which would interact with the positively charged 
lysines, typically located at or near the protein surface. The variability observed across the 
samples, illustrated by the large overlapped error bars of the data, is a result of the manual 
selection of the peak apex. This error could be minimized if the peak m/z value would have been 
selected based on the weighted mass determined by peak fitting or integration. Sample spectra 
from these trials are shown in Appendix I in Figures A.1.1 – A.1.56. 
 
2.3.2. Reductive Methylation of Hen Egg White Lysozyme Using Increasing Concentrations 
of Formaldehyde in the Presence of G-75 Sephadex and C18 Silica 
 Reductive methylation of hen egg white lysozyme was conducted in the presence of G-75 
Sephadex and C18 Silica media. Overall, the labeled samples exhibited low levels of labeling 
including controls, and poor reproducibility between the replicate samples of each of the five 
Figure 2.8. Graphical representation of the effects of increasing amounts of formaldehyde in 
the reductive methylation reaction at 1.2 mM, 2.5 mM, 4.9 mM,  9.8 mM when there reaction 
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trials. Samples were analyzed using MALDI MS determine the percent methylation. The average 
methylation values calculated from the five trials are presented in Figure 2.9. and exhibit the 
same trend of increased labeling with increased concentration of formaldehyde as shown in 
Figure 2.8. Typically C18 Silica media is used for reverse phase chromatography and the 
medium interacts with hydrophobic molecules. Thus, it should interact with hydrophobic regions 
of the surface of hen egg white lysozyme. Since lysine residues are typically located on or near 
the surface of proteins, they are more hydrophilic in nature; thus, in the presence of C18 media, 
the reductive methylation reaction-sites should be minimally protected by the media and should 
exhibit higher methylation values than other media. This result is observed for all concentrations 
of formaldehyde with the exception of the highest (9.8 mM). G-75 Sephadex has been shown to 
have a pH dependent interaction with hen egg white lysozyme; at pH 8 there is complete binding 
of the protein to the media, which decreases to 50% when the pH is decreased to 6.33 The 
reductive methylation reaction is performed at pH 7.5, a pH at which the majority of the protein 
Figure 2.9. Graphical representation of the effects of increasing amounts of formaldehyde in 
the reductive methylation reaction at 1.2 mM, 2.5 mM, 4.9 mM, and 9.8 mM, when the 
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should be bound to the media; however, the mechanism of this interaction has not been 
investigated. The selective binding interaction between lysozyme and G-75 Sephadex should 
ideally have an inhibitory effect on the protein, resulting in lower methylation values. However, 
the data from the experiments using this medium do not align with this hypothesis. Overall, the 
labeling of the samples from these experiments was much lower than previous experiments, even 
for the control samples. In comparison to the trials conducted using G-15 Sephadex and 
Lipophilic Sephadex, the anticipated change in labeling of these samples when media is present 
versus when there is no media is present was not observed. In fact, the low degree of labeling for 
control samples suggests that there are some additional variables influencing the labeling 
efficiency. In addition the concentration of formaldehyde used for labeling may have been 
problematic. MALDI- MS spectra of these experimental samples are shown in Appendix I in 
Figures A.1.57 – A.1.114. 
Aside from serving as a proof of concept, the experiments presented in Sections 2.3.1 and 
2.3.2. were used to determine which media were the best candidates for the residue assignment 
and the concentration of methylating reagent to be use for labeling. The low levels of 
methylation and the poor reproducibility from the five trials conducted using G-75 Sephadex and 
C18 Silica resulted in the omission of these two media from experiments used to calculate 
percent methylation. In contrast, the experiments conducted using G-15 Sephadex and Lipophilic 
Sephadex were more reproducible and demonstrated the expected trends based on predicted 
structural interactions. To achieve the overall goal of peak assignment, conditions were selected 
in which there was the greatest discrepancy in the labeling between samples in the presence of 
media. In addition, a moderate level of methylation was desired to allow for the second labeling 
reaction using natural abundance formaldehyde as the methylating reagent. This step is important 
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for MALDI MS experiments of tryptic peptides which will be discussed later in further detail. 
Moderate levels of methylation are also important for NMR studies conducted for peak 
assignment, as low levels of methylation result in less intense NMR peaks, making data analysis 
difficult. Thus, future experiments were conducted using 2.5 mM formaldehyde for moderate 
labeling levels and 9.8 mM formaldehyde to achieve complete labeling for controls.  
2.3.3. Reductive Methylation of Lysozyme in the Presence of 10 mg versus 100 mg of 
Lipophilic Sephadex and G-15 Sephadex  
 To further demonstrate the effects of chromatographic media on the labeling efficiency of 
reductive methylation of hen egg white lysozyme, experiments were conducted where the 
amount of media within the reaction mixture was varied from 10 mg to 100 mg and compared to 
controls labeled using 9.8 mM and 2.5 mM formaldehyde in the absence of media. The results in 
Figure 2.10 show the spot average of  the percent methylation of the two trials in which each 
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Figure 2.10. The effects on reductive methylation labeling of hen egg white lysozyme when 
Lipophilic Sephadex and G-15 Sephadex amounts are varied from 10 mg to 100 mg. 
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co-spot. As previously discussed in Section 2.3.1., samples labeled by reductive methylation in 
the presence of media show lower percent labeling values in comparison to those in which the 
media was absent. The results presented also suggest that the amount of media in the reaction 
mixture also affects labeling as samples with 100 mg of media had lower percent labeling in 
comparison to those with 10 mg of media. This result is most likely due to an increase in protein-
media interaction. The lower percent labeling values of samples labeled in the presence of 
Lipophilic Sephadex versus those labeled in the presence of G-15 Sephadex observed in the 
previous experiments is not observed. Instead, the labeling is about the same for the samples in 
each medium labeled using the same amounts. Figures from these experiments are shown in 
Appendix I in Figures A.1.115 – A.1.132. 
2.3.4. Determination of the Average Percent Methylation at Each Dimethylamine NMR 
Peak 
 In order to accomplish the overall goal of the assignment of the dimethylamine NMR 
peaks of reductively methylated hen egg white lysozyme, labeled samples were analyzed by 1D 
HSQC NMR and MALDI MS. Using both methods, labeling was quantified and compared to 
achieve assignment. The calculation of methylation at each dimethylamine peak was achieved by 
determining both the percent methylation of the intact protein determined by MALDI MS and by 
calculating the area of each NMR peak. Hen egg white lysozyme has a total of 7 reaction sites: 
the 6 -amino groups of the lysine residues within the sequence and N-terminal -amino group, 
which are represented by the peaks labeled in Figure 2.11. For peak assignment, control samples 
of hen egg white lysozyme were reductively methylated using 9.8 mM and 2.5 mM 13C 
formaldehyde. All samples were analyzed by MALDI MS to determine the percent methylation. 
The percent methylation values of samples methylated using the higher concentration of 
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MS spectra and 1D 1H-13C HSQC NMR spectra of the samples are shown in Appendix I in 
Figures A.1.133 – A.1.156. 
 
2.3.5. Determination of the Average Percent Methylation at the -Amine and N-Terminal 
-Amine of Reductively Methylated Hen Egg White Lysozyme  
 
The second component to this assignment method is to detemine the percent methylation 
at each reaction site of the protein. This was achieved by digesting the labled protein with typsin 
to generate peptides. The resultant peptide mixture was then analyzed by MALDI MS and the 
percent labeling of each peptide was determined. The resulting values are shown in Figure 2.14. 
The data represented in Figure 2.14 is visually similar to the percent methylation values 
determined using NMR data, shown in Figure 2.13. Both sets of data have one distinct value 
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Figure 2.12. Percent methylation values at each dimethylamine peak determined using the 
percent methylation of the intact protein calculated from MALDI MS data and NMR peak 
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Figure 2.13. Average percent methylation of each reaction site of reductively methylated 




























Average Percent Methylation of Lysine Residues and NMR Peaks from of 




p = 0.02 
p = 0.03 
Figure 2.14. NMR peak assignments to lysine residues of hen egg white lysozyme labeled 
using 2.5 mM 
13
C labeled formaldehyde by the comparison of percent methylation values 
determined by NMR and MALDI MS. 
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2.3.6. Assignment of Dimethylamine Peaks of Reductively Methylated Hen Egg White 
Lysozyme Using Lipophilic Sephadex and G-15 Sephadex 
 
The primary objective of this work was to address the issue of degenerate labeling 
encountered in previous studies, which limited the definitive assignment of the NMR peaks. The 
two methods used to combat this limiting factor were the reductive methylation of the protein 
with chromatographic media, Lipophilic Sephadex and G-15 Sephadex, in the reaction mixture. 
The substoichiometric labeling addresses the issues of degenerate labeling by taking into account 
the different rates of reaction of each lysine residue. This factor is important because the 
calculation of the percent labeling of the tryptic peptides considered the incorporation of natural 
abundance and 13C labeled formaldehyde at each reaction site. The results presented in Section 
2.3.1 and Section 2.3.2. demonstrate that in fact the concentration of the labeling reagents effects 
the completeness of the reaction, and thus the degree of labeling. The presence of the solid media 
in the reaction mixture shows some promise in addressesing the issue of degenerate labeling. The 
assignments of the dimethylamine peaks of hen egg white lysozyme were achieved through the 
comparison of the percent methylation values obtained using both the MALDI MS and NMR 
data shown in Figure 2.12. and Figure 2.13., respectively. These numerical values are listed in 
Table 2.3 of Appendix II. The explanation of assignments will be focused on peaks 1-5 because 
previous assignments of peaks 6 and 7 by Roberson and coworkers was acheived using an N-
terminal cleaving enzyme, aminopeptidase, and pH studies.22, 34 Briefly, peaks 6 and 7 are 
assigned to the -amino group of Lys1 and the -amino group of the N-terminus, respectively. In 
addition, this assignment is in agreement with the assignments made by Larda and coworkers.22-
23 The aminopeptidase studies, conducted by Roberson and coworkers, helped to identify which 
peak in the spectrum could be attributed to these two residues. The experiments, where the pH 
was varied, helped to make the definitive assignments as the labeling reaction yielded 
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substantially lower labeling at high pH resulting in a lower peak intensity in the NMR spectrum. 
In regard to the results from this work, the percent methylation values determined by both 
MALDI MS and NMR for peaks 6 and 7, which are assigned to Lys1 and the N-terminus, 
respectively, methylation values for peak 6, determined by both MALDI and NMR are in close 
agreement. However, the values for peak 7 and the N-terminal amine assignments are not in 
close agreement and thus, without confirmation from previous studies, the method presented 
herein would not have been able to achieve the definitve assignment of peak 7. The actual 
percent methylation and standard deviation values are listed in Table A.1.1 in Appendix I. The 
assignments for the lysozyme control labled with 2.5 mM hen egg white lysozyme, and the the 
samples labeled in the presence of Lipophilic Sephadex and G-15 Sephadex are shown in Figures 
2.14. - 2.16. Peak 1 was assigned to Lys97 as the values for the percent methylation calculated 
by both NMR and MALDI MS for peak 1 and Lys97 were the most highly labeled, except in 
the case where the most highly labeled peak was already previously assigned to peak 7. 
Consistently, there are slightly higher degrees of methyation for samples analyzed by MALDI 
for this particular assignment. The p values were calculated to determine if statistical variations 
in the methylation values determined by NMR and MALDI MS exists at the 95% confidence 
interval where p-values calculated to be less than 0.05 are considered statisitically diferent. 
Values for this particular assignment were not deemed statistically different. The assignment of 
peak 1 to Lys97 is in agreement with the assignment published by Brown and Bradbury.19Peak 
4 of the NMR spectrum was assigned to Lys96. The values for peak 4 in the NMR data are 
consistently the second lowest for all the data sets, and correlate well to those calculated for 
K96 in the MALDI data. The methyaltion of Lys96 is lower than that of Lys97 and Lys96, 
like Lys1, is adjacent to another reaction site.The proximity of the reaction sites can explain 
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why the rate of methylation for one is higher than the other as it may be a result of steric 
hinderance upon the incorporatation of the methyl groups. The assignment of peak 4 is in 
























Average Percent Methylation of Lysine Residues and NMR Peaks from of 
Reductively Methylated Hen Egg White Lysozyme Labeled in the Presence 





Figure 2.15. NMR peak assignments to lysine residues of hen egg white lysozyme labeled 
using 2.5 mM 
13
C labeled formaldehyde in the presence of Lipophilic Sephadex by the 

























Average Percent Methylation of Lysine Residues and NMR Peaks from of 
Reductively Methylated Hen Egg White Lysozyme Labeled in the Presence 
of G-15 Sephadex Using 2.5 mM Formaldehyde
NMR
MALDI
Figure 2.16. NMR peak assignments to lysine residues of hen egg white lysozyme of labeled 
using 2.5 mM 
13
C labeled formaldehyde in the presence of G-15 Sephadex by the 
comparison of percent methylation values determined by NMR and MALDI MS. 
67 
 
 The remaining three assignments have been tentatively assigned as Lys33 to peak 2, 
Lys13 to peak 3, Lys116 to peak 5. The assignment of these three peaks were made by ranking 
the average methylation values, from both data sets, in decreasing order. Assignments were 
performed in this manner due to the fact that while some of the methylation values for these 
three lysine residues are statistically different based on their calculated p-value, it is impossibile 
to definitively assign the peaks because the values are indistinguishable. In regard to agreement 
with previous assignments, peak 2 and peak 5 assigned to Lys33 and Lys116, respectively, 
aligns with the tentaive assignements made by Macnaughtan et al. and Roberson et al., who 
assigned these peaks in a pairwise faishion due to labeling degeneracy. However, in the work by 
Larda and coworkers, which was focused on assignments made using monomethylamino groups, 
they were able to make defintive assignments of peak 2 to Lys116 and peak 5 to Lys33. The 
assignment of peak 3 to Lys13 is in agreement with the original assignment published by 
Bradbury and Brown. Table 2.2 is an update from Table 2.1, showing the assignments made 
from this study aligns with the tentaive assignments made by Macnaughtan et al. and Roberson 
et al., who assigned these peaks in a pairwise faishion due to labeling degeneracy. However, in 
the work by Larda and coworkers, which was focused on assignments made using 
monomethylamino groups, they were able to make defintive assignments of peak 2 to Lys116 
and peak 5 to Lys33. The assignment of peak 3 to Lys13 is in agreement with the original 
assignment published by Bradbury and Brown. Table 2.2 is an update from Table 2.1, showing 
the assignments made from this study. 
Many of the percent methylation values determined by NMR, for all three sample types, 
exhibit higher values that those calculated by MALDI data. However, the major component that 
can influence the degree of labeling calculated is the fit of the experimental data for the 
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determination of peak areas which is reflected in the standard deviation of the NMR peak areas, 
with peaks that are hard to fit from being overlapped or low in intensity being problematic. In 
addition the p-values shown in Figures 2.14 – 2.16. belong to the assignments made for peaks for 




The use of reductive methylation as a chemical modification reaction to aide in the peak 
assignment has been previously studied. However, the success of the assignment methods was 
limited by several factors, including heavy reliance on structural data to make assignments and 
degenerate labeling. The assignment method presented in this chapter, does not rely on previous 
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6 eLys1 Lys1 Lys96 Lys1 Lys1 Lys1
7 Lys1 Lys1 Lys97 Lys1 Lys1 Lys1
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knowledge of the protein structure, aside from the amino acid sequence. In addition, it offers a 
solution to the issue of degenerate labeling by the use of substoichiometric concentrations of the 
labeling reagents and the incorporation of solid chromatographic media into the reaction mixture. 
The percent methylation values obtained from both NMR and MALDI MS allowed for the 
definitive assignments of peaks 1 and 4. In addition, values for peak 6 further supported its 
assignment to K1. Though the percent labeling for the MALDI data shows the variation in 
labeling at each lysine, the NMR data from peak 2, peak 3, and peak 5 are indistinguishable and 
only tentative assignments could be made. 
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METHODS FOR IMPROVING DIMETHYLYSINE SIGNALS IN NMR 
3.1. Introduction 
Protein structural studies by nuclear magnetic resonance (NMR) spectroscopy rely on the 
incorporation of stable isotopes such as 13C and 15N to increase the signal intensity and allow for 
correlation experiments to assist with spectral resolution and residue assignment.1-3 
Conventionally, isotopes are incorporated metabolically by the overexpression of protein in 
bacterial hosts, such as E. coli, using 15N-ammonium chloride and 13C-glucose.4 However, 
depending on the protein, expression can be challenging.5-7 The technological advancements of 
NMR experiments, along with the incorporation of stable isotopes, help with spectral overlap by 
spreading the spectral peaks throughout multiple dimensions and by making spectra less 
complicated because only peaks associated with the labels are observed. However, as protein 
size increases, spectral overlap can be a problem. In addition, the uniform incorporation of the 
stable isotopes is expensive in non-bacterial hosts.  
An alternative method for isotopic labeling is the site-specific chemical modification of 
proteins.8 An example of one such modification is reductive methylation, a reaction that 
selectively modifies the lysine residues and N-terminus of proteins. Using reducing and 
methylating reagents, such as dimethylamine-borane complex (DMAB) and 13C-formaldehyde, 
respectively, 13C-dimethyl groups are incorporated at the -amino groups of lysine residues and 
the -amino group of the N-terminus. The resulting 13C-dimethylamine peaks in the NMR 
spectrum are effective probes for studying proteins.9-11 One advantage to this labeling method is 
that it has little influence on protein conformation; thus, structural restraints for the reductively 
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methylated protein correlate to the native structure of the protein.12-13 Secondly, the reaction 
completely and selectively labels the lysine residues of the protein, which can be partly attributed 
to the solvent exposed positions of lysines within the protein structures.14 The method is also 
useful for labeling large proteins due to the favorable relaxation properties of the methyl 
groups.15-18 Despite the demonstrated usefulness of this labeling method, the lack of a direct 
assignment method mitigates its applicability. The majority of methods previously published for 
the assignment of dimethylamino groups of reductively methylated proteins rely on extensive 
structural data to make assignments.16, 19-20 An assignment method published by Macnaughtan et 
al. addressed the need for a direct assignment method, which did not rely on structural data, by 
presenting a method that relied on quantifying the extent of methylation at each dimethylamine 
peak in the NMR spectrum and of tryptic peptides analyzed by matrix assisted laser desorption 
ionization mass spectrometry (MALDI MS).21 Methylation values from each method were 
compared, and similar values of methylation from each technique led to partial assignments, 
where some were made in a pairwise fashion. The pairwise assignments were the result of 
similar levels of methylation, also known as degenerate labeling. The labeling degeneracy is a 
limitation of the method and adversely affects attempts for peak assignment.21 The degenerate 
labeling produced by this reaction is attributed to similar local chemical environments of the 
reductive methylation reaction sites, resulting in similar levels of the methyl group incorporation. 
This degeneracy makes definitive and accurate assignment difficult especially in regard to 
assignment methods such as the one detailed by Macnaughtan and coworkers, which relies on 
the determination of peak area for the calculations of percent methylation.21 Another limitation to 
this labeling method is poorly resolved and/or low intensity peaks, which makes peak fitting 
difficult.22-23 The poor resolution and low intensity of the dimethylamine peaks are the result of 
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line broadening from intermediate to slow exchange of the dimethyl groups.16, 24  Recent work 
published by Larda et al. addressed the issue of line broadening produced by dimethylamine 
peaks by proposing a methylation protocol that favors the production of monomethylamines.20 
However, this protocol is more labor intensive because the reaction readily proceeds to the 
production of dimethylamines. 
3.1.1. Project Overview 
The work detailed in this chapter focuses on methods that are tools for the improvement 
of the spectral resolution of dimethylamine peaks of reductively methylated proteins in 1D and 
2D 1H-13C-heteronuclear single quantum coherence (HSQC) NMR spectra. The effects of 
temperature and ethylenediaminetetraacetic acid (EDTA) addition (with and without cobalt, 
Co2+) were studied using reductively 13C-methylated hen egg white lysozyme (HEWL), papain, a 
cysteine protease from Carica papaya, and the C56S mutant of an inhibitor of a cysteine 
protease (ICP) isolated from the protozoan parasite Leishmania mexicana. The effect of pH on 
both reductively 13C-methylated lysozyme and ICP was also explored.25 The success of these 
tools in producing more resolved 13C-dimethylamine NMR peaks can aid in the determination of 
peak areas that can be useful for the assignment of peaks for structural studies of proteins. 
3.2. Methods and Materials 
3.2.1. ICP Expression 
The C56S mutant of cysteine protease inhibitor (ICP) from Leishmania mexicana was 
expressed from a pET28 (Novagen) derived plasmid in C4 Escherichia coli cells. (Lucigen).26 
The plasmid was gifted to our lab by the Smith lab at the University of Glasgow, UK. Cells were 
grown in 1 L cultures of LB broth (Fischer) with 100 g/ml kanamycin (Sigma) to an optical 
density at 600 nm of 0.7 at 37 °C followed by induction with 1 mM isopropylthiogalactoside 
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(IPTG) at 37 °C for 3 hours.24, 27 Cells were harvested by centrifugation at 3000 x g for 15 
minutes and stored at -80 °C until lysis. 
3.2.2. ICP Purification  
Cells were lysed in lysis buffer (20 mL of 10 mM Tris (Sigma), 150 mM sodium chloride 
(NaCl, Sigma), and 10 mM imidazole at pH 7.50, 2mL of Bugbuster (Novagen), 100 l of 
complete EDTA-free protease inhibitor (Roche), and 15L DNAase (Fischer)) by ultrasonic 
disruption and high pressure homogenization. ICP was purified from the cleared supernatant 
using His Pur cobalt resin (Thermo Scientific). The ICP fractions were further purified using a 
HiPrep 26/60 Sepahacryl S-100 gel filtration column using 20 mM potassium phosphate 
(K3
+PO4
-3), 150 mM sodium chloride (NaCl) at pH 7.2 as the running buffer. The purified ICP 
was dialyzed against 50 mM potassium phosphate at pH 7.5 using Amicon centrifugal filters 
with a 3 kDa molecular weight (MW) limit (Millipore) and reductively methylated as described 
below. Reductively methylated ICP samples were prepared for NMR analysis by exchange into 
buffers prepared in deuterium oxide (D2O). The buffer for ICP at pH 9.0 was 50 mM borate 
buffer (Sigma). For samples analyzed at pH 8.0 and pH 7.0, the buffer used was 20 mM 
potassium phosphate (Sigma). A 25 mM succinate buffer (Sigma) was used for samples analyzed 
at pH 5.0.  
3.2.3. Reductive Methylation 
Stock solutions of hen egg white lysozyme (Sigma), ICP, and papain were prepared at 5 
mg/mL in 50 mM potassium phosphate (K+PO4
+3) at pH 7.5. Stock solutions of dimethylamine-
borane complex (DMAB, Sigma) and 13C labeled formaldehyde at concentrations of 153 mM, 
for hen egg white lysozyme and ICP, and at 253 mM for papain were prepared fresh in Millipore 
water and kept on ice. To achieve dimethylation, an aliquot of DMAB, equivalent to a 1:4 molar 
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ratio of lysine to formaldehyde, was added to 500L aliquots of the respective protein stock 
solutions. The addition of DMAB was subsequently followed by the addition of 13C-
formaldehyde (Cambridge Isotope Laboratories) equivalent to a 1:8 lysine to formaldehyde 
molar ratio. The reaction mixture was incubated at 4 °C for two hours while mixing on an 
Orbitron Rotator I (Boekel Scientific). After incubation, a second aliquot of DMAB and 13C-
formaldehyde was added to the reaction mixture, followed by a second two hour incubation 
period. A final aliquot of DMAB, equivalent to a 1:2 lysine to formaldehyde molar ratio, was 
added and the reaction and the sample was incubated while mixing at 4 °C overnight for a total 
reaction time of 24 hours.  Following incubation, 6 mM ammonium sulfate (Sigma) was added to 
quench the reaction. Samples were allowed to incubate for an additional hour before exchanging 
into 50 mM potassium phosphate buffer at pH 7.50 using Amicon centrifugal filters with 3 kDa 
MW limits. Reductive methylation of the samples was repeated as described above using natural 
abundance formaldehyde (Sigma) as the methylating reagent. Following reaction quenching, the 
sample was dialyzed into 50 mM potassium phosphate buffer at pH 8.50 in deuterium oxide 
(D2O) (Cambridge Isotope Laboratories) for NMR analysis. 
3.2.4. Preparation of Cobalt-Containing Sample 
A 500 L aliquot of a 5 mg/mL stock solution of lysozyme in 50 mM potassium phosphate 
buffer at pH 7.5, was reductively methylated using an abbreviated version of the procedure 
outlined in Section 3.2.3, arresting the labeling reaction just before the first quenching step. The 
lysozyme sample was dialyzed against 50 mM Tris (Sigma) buffer at pH 8.0. Cobalt (II) chloride 
was added at a concentration of 53 nM, and the sample was incubated at 37 °C for 20 hours. 
After incubation, the sample was dialyzed against 50 mM potassium phosphate, 50 mM EDTA at 
pH 8.50 in D2O in preparation for NMR analysis. 
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3.2.5. NMR  
All NMR experiments were acquired using a Varian 700 MHz spectrometer equipped with a 
5 mm HCN 5922 probe. The majority of the 1D and 2D 1H-13C HSQC NMR spectra were 
acquired using a relaxation delay of 3-5 s, 2802-4529 Hz spectral width in the 1H dimension, and 
256 scans. One exception is the spectrum of reductively methylated lysozyme at 25 °C shown in 
Figure 3.1 A. This spectrum was acquired with 512 scans while the spectra represented in Figure 
3.1. B-D were acquired with 256 scans, thus the vertical scale was adjusted to account for that 
change. The vertical scales of the spectra represented in Figure 3.2. were also adjusted to 
compensate for changes in the gain values. The vertical scale of the spectrum in Figure 3.2. A 
was increased by a factor 1.8. The gain was decreased from 60 to 56, 48, and 44 for the 
acquisition of the spectra shown in Figure 3.2. D-F, respectively. Thus, the vertical scale was 
increased by a factor of 2.51 (Figure 3.2. D and 3.2. E) and by a factor 3.89 (Figure 3.2. F), 
respectively. For the 2D experiments, the parameters used are the same except for 880 Hz 
spectral width in the 13C dimension, 220-512 increments, and 4-8 scans.  
3.2.6 EDTA Titrations of Lysozyme and Papain 
Lysozyme and papain were reductively methylated as detailed in Section 3.2.3 and 
analyzed by 1D 1H-13C HSQC NMR as described in Section 3.2.5 at 25 °C. Aliquots from a 500 
mM EDTA solution at pH 8.50 (for HEWL) and pH 5.00 (for papain) were added to the sample 
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addition of EDTA to the papain samples did not have an effect on the peak shape or dispersion of 
the dimethylamine peaks in the spectra. Thus, the results on display in Figure 3.3. provide an 
example of the electrostatic effects of EDTA on reductively methylated papain in 50 mM 
succinate buffer with 150 mM NaCl at pH 5.0. Since the increasing concentration of EDTA in 
the sample had minimal effects on the resolution and chemical shift of the 13C-dimethylamine 
peaks, it can deduced that there is little interaction between the EDTA and the dimethylamine 
peaks. This is likely due to the low pH conditions of the buffer, which limits the electrostatic 
interactions of the EDTA with the 13C-dimethyl groups. The limit on the electrostatic interaction 
can be attributed the deprotonated state of papain at pH 5.00, which is higher than the protein’s 
isoelectric point (pI), which is approximately 4.5. In addition sodium cations of the NaCl in the 
buffer can also interact with the EDTA as well, further limiting electrostatic interactions.  
3.3.3. Reductively 13C-Methylated Lysozyme in the Presence of Cobalt and EDTA  
 Figure 3.4. shows the 2D 1H-13C HSQC NMR spectra of a reductively methylated hen 
egg white lysozyme (RM-HEWL) control sample and a RM-HEWL sample in the presence of 
cobalt and EDTA, 3.4. A and 3.4. B, respectively.  The 13C-dimethylamine peaks of lysozyme 
shift upfield by varying amounts when cobalt and EDTA are present (Figure 3.4. B). The 
presence of EDTA and cobalt in a reductively 13C-methylated lysozyme sample produces peaks 
that are narrower in width and shifted upfield (Figure 3.4. B) compared to no EDTA (Figure 3.4. 
A) and EDTA-only spectra (Figure 3.2. E). The significant change in chemical shift when cobalt 
is present can be attributed to the paramagnetic properties of cobalt, resulting in pseudocontact 
shifts (PCS’s). PCS’s from cobalt are an effective way to measure distances on protein structures 
given a specific binding site for cobalt.28 Because the magnitude of the PCS for each 13C-
dimethylamine groups varies, the cobalt binding site on reductively 13C-methylated lysozyme is 
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specific. These results demonstrate the potential of using PCS’s to measure distances using the 
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Figure 3.4. These figures demonstrate the effect of cobalt on the 13C-dimethylamine peaks 
of reductively 13C-methylated lysozyme in a 2D 1H-13C HSQC NMR spectrum. The 
spectrum in (A) is of the control sample with no cobalt, and (B) is the spectrum with the 
addition of 0.53 nM cobalt in 50 mM K3PO4, 50 mM EDTA at pH 8.5. 
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groups of Glu35, which is located in the active site of the protein, but cannot be definitely 
assigned due to the excess EDTA in solution present, which chelates the cobalt, helping to keep 
it in solution, due to its insolubility in phosphate containing buffers.29-30 
3.3.4. Reductively 13C-Methylated Lysozyme at Various pH 
 The effect of pH on the 13C-dimethylamine peaks of reductively methylated HEWL is 
shown in Figure 3.5. As the pH is increased from 6.65 to 8.10 (Figures 3.5 A-C), the chemical 
shift changes and the peak linewidth decreases. Peaks 1 and 5 are broad (split peaks at pH 6.65 
(Figure 3.5. A)) but coalesce and sharpen as the pH is increased (Figures 3.5. A, B). Peak 6 is 
also very broad and is only visible at higher pH. Peak 7 shows a dramatic change in chemical 
shift from pH 6.65 to 8.10, with a 0.4 ppm shift upfield in the 1H dimension and a 0.4 ppm shift 
downfield in the 13C dimension. The 2D 1H-13C HSQC NMR spectra of reductively 13C-
methylated lysozyme in Figure 3.5. demonstrate the effect of pH on the chemical shift and line 
width of the 13C-dimethylamine peaks.  The linewidth change is best illustrated by peak 6, which 
is barely visible at pH 6.65 and becomes more intense as the sample pH is increased.  The 
change in the linewidth is likely due to the dynamics associated with the protonated and 
deprotonated states of the 13C-dimethylamine. The pKa of the lysine 
13C-dimethylamine groups 
ranges from 9.29-10.23, so as the pH of the sample is increased, the equilibrium is shifted from 
the protonated dimethylamine to a mixture of protonated and deprotonated species.31-32 Changes 
in the exchange rates are clearly observed for peaks 1 and 5. At pH 6.65 the peaks are split, 
indicating slow chemical exchange between two states.  At pH 7.36, the peaks coalesce; and at 
pH 8.10, a single sharp peak is observed, indicating fast exchange.  The drastic manner in which 
pH can affect the chemical shifts of the 13C-dimethylamine peaks is seen in the upfield shift of 
peak 7 in the proton dimension. This peak was identified as the N-terminal 13C dimethylamine, 
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which has an approximate pKa of 7.0.
16, 33 Since the pH range is from 6.65 - 8.10, the N-terminal 
13C-dimethylamine equilibrium goes from mostly protonated to mostly deprotonated, suggesting 
that the large chemical shift change is due to the loss of the proton.  The direction of the shift 
upfield corroborates this interpretation as the lone pair of the deprotonated form shields the 
methyl groups. 
3.3.5. Reductively 13C-Methylated ICP at Various pH 
 Figures 3.6. and Figure 3.7. illustrate the effects of pH on the 2D 1H-13C HSQC NMR 
spectra of reductively 13C-methylated ICP.  Figure 3.6. shows reductively 13C-methylated ICP at 
pH 5.0, 7.0, 8.0, and 9.0, demonstrating that the resolution of the 13C-dimethylamine peaks of 
ICP is highly dependent on pH. At pH 5.0 (Figure 3.6. A), the 13C-dimethylamine peaks are well 
resolved. However, when the pH is adjusted to neutral (Figure 3.6. B) and to pH 8.00 (Figure 
3.6. C), the peaks become overlapped. At pH 9.0, the peaks begin to separate again, becoming 
more resolved with less peak overlap. The ability to manipulate the amount of peak overlap in 
NMR spectra of reductively 13C methylated ICP by adjusting the pH is shown in Figures 3.6. The 
13C-dimethylamine peaks are well-resolved at both pH 5.0 and 9.0 (Figures 3.6. A and 3.6. D). 
Work by Abraham et al. indicated that the resolution of the 13C-dimethylamine NMR peaks is 
improved when the buffer pH is within the range of the side chain pKa values of the protein’s 
lysine residues.24 The lysine residue pKa values vary over a range of 9.0-10.0, so the pH 9.0 
spectrum of reductively 13C-methylated ICP agrees with the published observation. However, the 
pH 5.00 sample is also well-resolved and provides an alternative pH in which to study this 
protein. More peaks are observed at pH 5.0 compared to pH 9.0. Some of the extra peaks are due 
to slow exchange, but others may be from peaks that are two broad to be observed at pH 9.0. 
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The Bradford and BCA assays are common colorimetric assays used to determine the 
concentration of proteins.1-3 The assays are simple, have high sensitivity, and are visually 
satisfying. The color formation observed in the Bradford assay is a result of interactions between 
the protein and the Coomassie blue G-250 dye (Figure 4.1. A). Under very acidic conditions, the 
dye is red in its protonated state. Through electrostatic and hydrophobic interactions with a 
protein molecule, the anionic (-1 net charge), blue form of the dye is stabilized.4-7 In the BCA 
assay, color formation is the result of two reactions. First, cupric ions (Cu+2) are reduced to 
cuprous ions (Cu+) by the protein under alkaline conditions via the biuret reaction.8 Then, a 
complex between Cu+ and two molecules of bicinchoninic acid forms, which gives the 
characteristic purple color of the assay (Figure 4.1. B).2 The intensity of the color formed by 
these assays is measured by absorbance photometry at 595 nm and 562 nm for the Bradford and 
BCA assays, respectively. Typically, standard solutions of bovine serum albumin (BSA) are used 
to produce a calibration curve of absorbance versus mass concentration. Assuming that the 
proteins react in the same manner as the BSA standard, the unknown concentration can be 
determined. Unfortunately, the assumption that the assay response is universal is not always 
valid, and protein-to-protein variability can lead to an over- or under-estimation of the analyte-
protein’s concentration.9 
 
This chapter previously appeared as Brady, P. N.; Macnaughtan, M. A. Evaluation of 
Colorimetric Assays for Analyzing Reductively Methylated Proteins: Biases and Mechanistic 
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for protein regulation and function. Glycosylation is an example of a PTM, which involves the 
addition of a mono- or polysaccharide to a protein. Fountoulakis et al. investigated the variability 
of the Bradford, BCA, and Lowry assays in quantifying several glycosylated proteins in 
comparison to the unmodified protein.10 They concluded that glycosylation interfered with the 
assay responses, resulting in an under-estimation of the glycoprotein concentration with the 
Bradford assay and an over-estimation of the glycoprotein concentration with the BCA and 
Lowry assays.10 
Lysine methylation is a common PTM found in biological samples and can be mimicked 
using the reductive methylation reaction.12 As a PTM, lysine methylation is an important and 
complex modification involved in protein regulation and signaling.13 Biological methylation of 
lysyl ε-amino groups can exist as mono-, di-, or tri-methylated. Mono- and di-methylation of 
lysine residues can be produced chemically using the reductive methylation reaction. Reductive 
methylation selectively incorporates methyl groups at the ε-amino group of lysine residues and 
the α-amino group of the N-terminus without disturbing the structure, and often activity, of the 
protein.12,14 Formaldehyde is used as the methylating reagent with a reducing reagent, such as 
dimethylamine-borane complex (DMAB).15 In the presence of excess reagents, the reaction adds 
two methyl groups to each primary amine. Reductive methylation is commonly used in X-ray 
crystallography because the modification rarely alters the protein’s overall structure and aids 
crystallization.14 The modification is also useful for studying proteins by nuclear magnetic 
resonance (NMR) spectroscopy because 13C-formaldehyde is used to add 13C-methyl groups as 
isotopic labels.16-17 The 13C-methyl groups are sensitive probes for investigating structural and 
dynamic properties of proteins and their complexes by NMR.16,18-39 Because of the extensive use 
of reductive methylation in the study of proteins and the natural occurrence of methylated 
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proteins, it is necessary to evaluate the effect, if any, of methylation on the response of 
commonly used concentration assays. 
In this study, we investigate the effect of lysine methylation on the Bradford and BCA 
assays. Amino acid composition and hydrophobicity can bias the responses of the Bradford and 
BCA assays, so reductive methylation may alter the accuracy of these assays. Commonly 
available proteins with a range of lysine content, including hen egg white lysozyme (HEWL), 
bovine serum albumin (BSA), and ovalbumin, were used to test the variability in the assays’ 
responses. 
4.2. Methods and Materials 
4.2.1. Materials 
Acetonitrile, ammonium sulfate, BSA (catalog number A7030), dimethylamine borane 
complex (DMAB), formaldehyde, HEWL (catalog number l6876), albumin from chicken egg 
white (ovalbumin, catalog number A5503, Grade V), potassium phosphate (monobasic and 
dibasic), sinapinic acid, trifluroacetic acid, L-lysine hydrochloride, and Nε,Nε-dimethyl-L-lysine 
hydrochloride, anhydrous caffeine, and sodium 3-(trimethylsilyl)-1-propanesulfonic acid (DSS) 
were purchased from Sigma Aldrich. The BCA assay kit and Coomassie Plus (Bradford) assay 
reagent were purchased from Fischer Scientific/Pierce. Corning UV-transparent half-area 96-
well plates were purchased from VWR.  Deuterated water (D2O) was purchased from Cambridge 
Isotope Laboratories. Bio-Gel P-4 size exclusion chromatography resin was purchased from Bio-
Rad.  All water used was supplied from a Millipore Direct-Q 3 ultrapure water system. 
4.2.2. Sample Pathlength Determination 
 Because a microplate spectrophotometer was used to measure the absorbance, the 
pathlength varied with the volume of the sample. The method of McGown et al. was used to 
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determine the sample pathlength and is an option in the Gen5 software for the BioTek 
PowerWave XS2 microplate spectrophotometer used in this study.40 Briefly, the absorbance of 
water at 977 nm and 900 nm are subtracted and divided by the known absorbance of water at 977 
nm and 1 cm (0.180 Abs) to give the pathlength in cm. The pathlength of replicate samples of 
water at 100, 120, and 200 L were measured in a half-area 96-well plate at 25 or 37 C. The 
average pathlength values and 95% confidence levels are summarized in the Appendix II in 
Table A.2.1. The average pathlength values were used to normalize the measured absorbance to 
1 cm. 
4.2.3. Extinction Coefficients at 280 nm 
 To determine if methylation of the primary amines added significantly to the overall 
absorbance at 280 nm (Abs280nm) of a protein, the molar extinction coefficients (ε280’s) of L-
lysine (Lys) and Nε,Nε-dimethyl-L-lysine (DM-Lys) were determined in PBS buffer (50 mM 
potassium phosphate, 100 mM NaCl, pH 7.52). 50 g/L solutions of Lys and DM-Lys were 
prepared by weighing at least 10.0 mg of material and dissolving in the appropriate amount of 
buffer. The Abs280nm was measured using 100 μL of sample in a 96-well plate with a BioTek 
PowerWave XS2 microplate spectrophotometer at 25 C. The absorbance values were corrected 
for the background absorbance of buffer and normalized to a 1 cm pathlength using the average 
pathlength of 100 μL of water (0.568 ± 0.002 cm). To correct for differences in the moisture-
content of Lys and DM-Lys, the concentration of each solution was determined using 
quantitative NMR with an internal standard, anhydrous caffeine.41-42 A 50 mM stock solution of 
caffeine was prepared in D2O. NMR samples were prepared by diluting the stock solutions to 
make “2 mM” Lys or DM-Lys, 1 mM caffeine, and 0.01% DSS (chemical shift reference) in 
D2O. The samples were analyzed using a 400 MHz Bruker instrument at 25 °C using a relaxation 
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delay of 2 s, an acquisition time of 4 s, a 30 pulse width, and 8 scans. The total area of the 
caffeine methyl peaks and the Lys or DM-Lys methylene and Hα peaks was determined by 
integration. The relative peak area was used to calculate the concentration of Lys and DM-Lys in 
each stock solution. The pathlength corrected Abs280nm were divided by the concentrations to 
give the molar ε280’s of Lys and DM-Lys in PBS buffer in units of M
-1cm-1. 
 The mass ε280’s were determined for each unmodified protein in water and in PBS buffer 
at 25 C. Stock solutions of each unmodified protein (HEWL, BSA, and ovalbumin) were 
prepared in triplicate at a concentration of 1.00 g/L by weighing at least 10.0 mg of protein and 
dissolving in an appropriate volume of water or PBS buffer. Aliquots of the stock solutions were 
added to a 96-well plate and diluted to a final volume of 100 μL with water or PBS buffer. The 
final concentrations for BSA and ovalbumin were 0, 0.2, 0.4, 0.6, 0.8, and 1.0 g/L and for 
HEWL were 0, 0.1, 0.2, 0.3, 0.4, and 0.5 g/L. These concentration ranges were chosen to ensure 
that the maximum absorbance values were less than 1.0. The Abs280nm was measured with a 
BioTek PowerWave XS2 microplate spectrophotometer after incubating the samples at 25 C for 
5 minutes. The absorbance values were corrected for the background absorbance of water or 
buffer and normalized to a 1 cm pathlength using the average pathlength of 100 μL of water 
(0.568 ± 0.002 cm). The slope, intercept, and correlation coefficient (R2) of the absorbance 
versus the concentration was calculated using linear regression analysis. Because the absorbance 
values were corrected for a pathlength of 1 cm, the slope values give the mass ε280’s in units of  
g-1 L cm-1. The average ε280’s and 95% confidence intervals were calculated for each protein in 
water and in PBS buffer. The molar ε280’s were calculated using the average molecular weight of 
the proteins as determined by matrix assisted laser desorption ionization mass spectrometry 
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(MALDI MS). The molar ε280’s were used to determine the concentration of the proteins after 
reductive methylation. 
4.2.4. Reductive Methylation 
Stock solutions of unmodified HEWL, BSA, and ovalbumin were prepared at a 
concentration of 5 g/L in 50 mM potassium phosphate buffer, pH 7.50. Reductive methylation of 
all proteins was performed using 500 μL aliquots of the protein stock solutions. Stock solutions 
of DMAB (1.0 M) and formaldehyde (1.0 M) were prepared fresh. An aliquot of DMAB was 
added to each protein in a 20:1 molar ratio (DMAB to protein amino groups) followed by an 
aliquot of formaldehyde in a 40:1 molar ratio (formaldehyde to protein amino groups). The 
samples were incubated at 4 °C while shaking for 2 hours. After 2 hours, a second aliquot of 
DMAB (20:1) and formaldehyde (40:1) were added, followed by a second 2 hour incubation 
with shaking. A final aliquot of DMAB (10:1) was added to each sample, and the samples were 
incubated overnight at 4 °C while shaking for a total reaction time of 24 hours. After 24 hours, 
the reactions were quenched by adding ammonium sulfate to a final concentration of 10 mM. 
The reductively methylated samples were then exchanged into PBS buffer using a Bio-Gel P4 
size exclusion column (7 mL of media) at a flow-rate of 0.2 mL/min. The eluting protein was 
monitored by absorbance photometry at 280 nm using a Bio-Rad BioLogic DuoFlow F10 
Workstation, and the fractions with reductively methylated protein were pooled. 
The concentration of the reductively methylated samples was calculated by measuring the 
Abs280nm and using the determined molar 280’s in PBS buffer for the unmodified proteins. The 
Abs280nm of each reductively methylated sample was analyzed in triplicate by diluting 50 μL 
aliquots of the pooled fractions to 200 μL with PBS buffer in a 96-well plate. Buffer blanks and 
water were run in triplicate (200 μL). After correcting for the blank absorbance of the buffer, 
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correcting for dilution, and normalizing to a 1 cm pathlength using the average pathlength of 200 
μL of water (1.102 ± 0.002 cm), the average absorbance values were divided by the molar ε280’s 
to give the concentrations of the reductively methylated samples. The mass concentration of each 
sample, in units of g/L, was calculated using the average molecular weight of the reductively 
methylated proteins determined by MALDI MS.   
4.2.5. MALDI MS Sample Preparation and Analysis 
MALDI MS analysis of the unmodified and reductively methylated proteins was 
performed to confirm methylation. The proteins (1 mL of approximately 5 g/L) were desalted 
into water using a Bio-Gel P-4 size exclusion column (7 mL of media) at a flow-rate of 0.2 
mL/min. A volume containing approximately 100 pmol of protein (as determined by the 
Abs280nm) was dried using a centrifugal evaporator (Savant SPD121P Speedvac Concentrator) 
and reconstituted in 2 μL of matrix (a saturated solution of sinapinic acid in 30% acetonitrile, 
0.1% trifluoroacetic acid). The protein-matrix mixture (1 μL) was spotted on a MALDI target 
(MTP 384, Bruker) and allowed to dry under ambient conditions. Unmodified and reductively 
methylated samples were analyzed using a Bruker UltrafleXtreme operating in linear mode with 
a mass-to-charge ratio (m/z) range of 5,000-70,000. A nitrogen laser was used at 89-92% power, 
and 2000 laser shots were averaged for each spectrum. Using Origin software, the spectra were 
smoothed using either the Savitzky-Golay method (5 coefficients, 2nd order polynomial; BSA 
and HEWL) or a 0.05 Hz low pass, fast Fourier transform filter (ovalbumin). To determine the 
molecular weight of the proteins, the peaks were either fitted to a Gaussian curve (BSA and 





4.2.6. Bradford Assay 
Protein solutions were made at 50 mg/L from the stock solutions of unmodified and 
reductively methylated protein. Aliquots of the 50 mg/L solutions (2, 4, 8, 12, 16, and 20 μL) 
were added to a 96-well plate, and PBS buffer was added to bring the total sample volume to 20 
μL. Blank samples of 20 μL of buffer were prepared in triplicate. Coomassie reagent (100 μL) 
was added to each well, mixed by shaking, and incubated at 25 C for 5 min. The absorbance at 
595 nm (Abs595nm) was measured with a BioTek PowerWave XS2 microplate spectrophotometer.  
The absorbance values were corrected by subtracting the average absorbance of the blank 
samples and normalized by dividing by the average pathlength of 120 L of water (0.679 ± 
0.003 cm). The normalized absorbance values were plotted versus the mass concentration (g/L). 
The data were fitted to a linear equation using the least squares method. Since the absorbance 
values were corrected to a 1 cm pathlength, the slopes are equal to the assay responses in units of 
g-1 L cm-1. The average response and 95% confidence intervals were calculated for each sample. 
4.2.7. BCA Assay 
Protein solutions were made at 250 mg/L from the stock solutions of unmodified and 
reductively methylated protein solutions. Aliquots of the 250 mg/L solutions (2, 4, 8, 12, 16, and 
20 μL) were added to a 96-well plate, and PBS buffer was added to bring the total sample 
volume to 20 μL. Blank samples of 20 μL of buffer were prepared in triplicate. Fresh BCA 
reagent was prepared following the manufacturer’s instructions, and 100 μL was added to each 
well, mixed by shaking, and incubated at 37 C for 30 min. The absorbance at 562 nm (Abs562nm) 
was measured immediately with a BioTek PowerWave XS2 microplate spectrophotometer. The 
absorbance values were corrected by subtracting the average absorbance of the blank samples 
and normalized by dividing by the average pathlength of 120 μL of water (0.679 ± 0.003 cm). 
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The normalized absorbance values were plotted versus the mass concentration (g/L). The data 
were fitted to a linear equation using the least squares method. Since the absorbance values were 
corrected to a 1 cm pathlength, the slopes are equal to the assay responses in units of g-1 L cm-1. 
The average response and 95% confidence intervals were calculated for each sample. 
4.3. Results and Discussion 
4.3.1. Reductive Methylation and MALDI MS Analysis 
Unmodified and reductively methylated samples were analyzed with MALDI MS and 
compared to assess the extent of methylation. A 100% conversion to the dimethylated species 
would indicate that all lysines and the N-terminus of the protein had undergone the addition of 
two methyl groups at the ε-amino groups and the α-amino group. Figure 4.2 shows the mass 
spectra of unmodified and reductively methylated BSA, HEWL, and ovalbumin. The unmodified 
mass, average mass of the reductively methylated samples, and average fraction methylated is 
reported in Table 4.1. BSA and HEWL were reductively methylated reproducibly with 86 ± 3% 
and 100 ± 1% methylation based on the mass shifts. Ovalbumin is a mixture of cleaved and full-
length proteins, each with an N-linked glycosylation site.43 The ovalbumin samples consistently 
ionized poorly in MALDI MS, which is usual for glycoproteins. Electrospray ionization MS was 
attempted, but also gave signals with low signal-to-noise ratios. The average fraction methylated 
for the cleaved and full-length ovalbumin was calculated to be 91 ± 2% and 77 ± 17%, 
respectively. Unlike the Gaussian fits to the BSA peaks, the correlation coefficients for the 
ovalbumin peaks ranged from 0.5071 – 0.9730 with better fits to the cleaved ovalbumin peaks.  
Based on the better fit and higher reproducibility of the cleaved ovalbumin, the ovalbumin 
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measured in water and in buffer is the apparent ε280’s for HEWL with a 12% difference (asterisk 
in Table 4.2.). The molar ε280’s and propagated errors are also listed in Table 4.2 and were 
calculated by multiplying the mass ε280’s in PBS buffer with the mass of the proteins determined 
by MALDI MS (Table 4.1.).  
 
After the reductive methylation reaction, the protein concentration must be empirically 
determined because some protein is lost to precipitation and/or adhesion to surfaces. If the 
dimethyl modifications do not contribute significantly to the Abs280nm, the ε280’s of the 
unmodified proteins can be used to determine the concentration of their reductively methylated 
counterparts. To test this assertion, the molar ε280’s of Lys and DM-Lys were determined and 
compared. Lys and DM-Lys stock solutions were prepared, and the molar concentrations were 
determined using quantitative NMR to correct for moisture in the weighed samples.  
Integrated 1H NMR spectra of each compound, with caffeine as an internal standard, are 
shown in Appendix II in Figure A.2.1. The blank and pathlength corrected Abs280nm’s for the 
stock solutions were divided by the molar concentrations to give the molar ε280’s of Lys and  
DM-Lys in PBS buffer of 0.72 M-1cm-1 and 0.70 M-1cm-1, respectively. The magnitude and 
difference between the measured ε280’s are small compared to the molar ε280’s of the proteins, 
Table 4.1. Molecular Weights of Unmodified and Reductively Methylated Proteins 











BSA 66,165 67,611 ± 56 1,447 86 ± 3 
HEWL 14,297 14,494 ± 2 197 100 ± 1 
Ovalbumin 
(cleaved) 39,898 40,406 ± 12 508 91 ± 2 
Ovalbumin 
(full-length) 44,190 44,645 ± 98 455 77 ± 17 
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which range from 26 x 103 to 40 x 103 M-1cm-1 (Table 4.2). Even for BSA, which has 59 lysine 
residues, the difference between Abs280nm’s of unmodified and reductively methylated BSA is 
less than 0.01%. Therefore, the molar ε280’s of the unmodified proteins can be used to determine 








The concentrations of the reductively methylated samples were determined by measuring 
the Abs280nm’s and dividing by the apparent ε280’s of the unmodified proteins in PBS buffer. 
Initially, stock solutions (50 and 250 mg/L) of the reductively methylated proteins were 
incorrectly made based on the calculated concentration using the mass ε280’s. The mass ε280 is 
widely reported for proteins because the exact mass of a protein is difficult to obtain (especially 
if the protein is a mixture) and the common colorimetric protein assays, including the Bradford 
and BCA assays, assume a composition-independent response. The Abs280nm of a protein, on the 
other hand, depends on the composition because the absorbance is primarily due to the number 
of tyrosine, tryptophan, and cystine residues.48 Because the Abs280nm depends on the moles of 
protein and not the mass, the molar ε280’s of the unmodified and reductively methylated proteins 
is the same, but the mass ε280’s are different by the ratio of the molecular weights. Therefore, the 
stock solution concentrations were corrected using the ratio of the masses of the reductively 
Table 4.2. Mass and Calculated Molar Extinction Coefficients at 280 nm and 25 C 





(g-1 L cm-1) 
Mass ε280 in PBS 
(g-1 L cm-1) ± 
95% CI 
Mass ε280 in 
water 
(g-1 L cm-1) ± 
95% CI 
Molar ε280 in PBS 
(mM-1 cm-1) ± 95% 
CI 
BSA 0.667 44 0.61 ± 0.06 0.61 ± 0.01 40 ± 4 
HEWL 2.64 45-46 2.26 ± 0.17* 2.56 ± 0.14* 32.3 ± 2.4 
Ovalbumin 0.69 – 0.76 47 0.63 ± 0.03 0.63 ± 0.02 26 ± 1 
   * p = 0.004 
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methylated and unmodified proteins determined by MALDI MS (Table 4.1.) effectively using 
the molar ε280nm’s instead of the mass ε280nm’s to determine the concentrations. The corrected 
concentrations for the 50 mg/L stock solutions are 50.69, 51.09, and 50.57 mg/L and for the 250 
mg/L stock solutions are 253.44, 255.47, and 252.86 mg/L for BSA, HEWL, and ovalbumin, 
respectively. 
4.3.3. Bradford Assay 
 The Bradford assay responses of triplicate samples of unmodified and reductively 
methylated proteins are summarized in Figure 4.3. Typically, BSA is used as a standard for the 
Bradford assay, and a calibration curve based on the mass concentration of BSA is used to 
determine the unknown concentration of a protein. Using the Bradford assay in this manner 
assumes that the color intensity (Abs595nm) is composition-independent such that the mass 
sensitivity (g-1 L cm-1) of the assay is the same for every protein. Based on our results in Figure 
4.3., this assumption is valid for unmodified BSA and HEWL, which have similar responses of 
46 ± 5 g-1 L cm-1 and 45 ± 3 g-1 L cm-1, respectively. Unmodified ovalbumin, however, has a 
significantly lower response of 33 ± 1 g-1 L cm-1. This result is not surprising because ovalbumin 
is a glycoprotein. A similar decrease in response for glycoproteins in general, and ovalbumin 
specifically (33% decrease), has already been demonstrated.10,49 The color production in the 
Bradford assay occurs when the blue, anionic form of the dye is stabilized, typically through 
electrostatic and hydrophobic interactions. The ovalbumin glycan comprises approximately 3-4% 
of the total mass and is mainly composed of neutral, high-mannose- or hybrid-type 
oligosaccharides.50-51 While the glycan mass alone does not explain the approximately 27% 
decrease in sensitivity, it is likely that the glycan competes with the dye by forming hydrogen 
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groups for the Coomassie blue G-250 dye upon methylation. The methyl groups may sterically 
hinder the electrostatic interaction with the dye’s sulfonic groups or decrease the accessibility of 
the amine by binding hydrophobic groups on the protein. BSA, in particular, shows a larger 
difference in response, likely because it has the highest density of lysines residues with 0.89 
lysines per kDa of protein. HEWL and ovalbumin have nearly half this density with 0.42 and 
0.46 lysines per kDa of protein, respectively, suggesting that the proportion of methylated lysines 
in the protein is important to consider when using the Bradford assay. 
4.3.4. BCA Assay 
 The BCA assay responses of triplicate samples of unmodified and reductively methylated 
proteins are summarized in Figure 4.4. The BCA assay responses of the unmodified proteins are 
16.6 ± 2.0, 22.7 ± 0.4, and 15.1 ± 0.6 g-1 L cm-1 for BSA, HEWL, and ovalbumin, respectively. 
Unlike the Bradford assay responses, BSA and ovalbumin have similar responses, and HEWL is 
significantly higher. The color formation in the BCA assay is mainly due to Cu2+ reduction by 
cysteine, cystine, tyrosine, tryptophan, and the backbone amide groups, with the cysteine and 
cystine residues being the most reactive.2,11,53 While the color formation cannot be predicted 
based on the sum of the individual color-producing components,11 in the case of BSA, HEWL, 
and ovalbumin, there is a correlation between the BCA assay response and the weight percentage 
of cysteine, cystine, tyrosine, and tryptophan residues (Figure 4.5.). The similar responses of 
ovalbumin and BSA contradict results by Fountoulakis et al., where the BCA assay gave an 
overestimation of 148% for ovalbumin when BSA was used as the calibration standard.10 The 
primary difference between our work and Fountoulakis et al. is the temperature of the BCA 
reaction; we incubated our samples at 37 C and Fountoulakis et al. at 60 C. While 
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the tertiary ε-dimethylamino groups likely contribute to the increased BCA assay responses, 
increasing the concentration of the deprotonated ε-dimethylamine and favoring Cu2+ binding.   
 The results of this study are relevant to biological methylation of lysine residues. 
Biological methylation can exist as mono-, di-, or tri- methyl-lysine. For the Bradford assay, the 
extent and proportion of methylation should be considered. If the methyl groups hinder binding 
to the Coomassie blue G-250 dye, then the assay response will decrease with increasing numbers 
of methyl groups. The concentration of a heavily tri-methylated protein may be underestimated 
when analyzed with the Bradford assay. On the other hand, if methylation occurs on a small 
fraction of lysine residues in a protein, the Bradford assay will likely give the same response as 
the unmodified protein. The effect of biological methylation on the BCA assay response is more 
complicated due to the differences in the pKa values of lysyl ε-amines, ε-monomethylamines, 
and ε-dimethylamines near the assay pH and the lack of an ionizable group on the lysyl ε-
trimethylamine. For lysyl ε-amino groups on proteins, the unmodified ε-amine pKa is 11.0 ± 
0.4,60-61 the ε-monomethylamine pKa is 10.9 ± 0.3,
16,29 and the ε-dimethylamine pKa is 10.1 ± 
0.3.16,18,26,29  These values follow the typical trend, where the pKa of the secondary amine is the 
same or higher than the primary amine and the pKa of the tertiary amine is lower than the 
primary amine.62 Based on the rationale that the lower pKa of the lysyl ε-dimethylamine allows 
for Cu2+ binding in the BCA assay, the effect of a lysyl ε-monomethylamine would be the same 
as an unmodified lysyl ε-amine. Similarly, the lack of an ionizable group on a lysyl ε-
trimethylamine would result in a decrease in the BCA assay response compared to the 
unmodified lysyl ε-amine. 
 In conclusion, the dimethylation from reductive methylation does not greatly alter the 
response of the Bradford assay, which can be used to determine the concentration of reductively 
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methylated proteins with nearly the same accuracy as determining the unmodified proteins. The 
use of a reductively methylated standard may compensate for the slight decrease in the Bradford 
assay response, but the composition of the standard should match the density of lysine residues 
in the analyte-protein. The BCA assay response increases upon reductively methylation, 
providing insight into the role of lysine residues in binding Cu2+. For studying proteins with 
biological methylation, the Bradford assay is recommended due to the varying effects of mono-, 
di-, and tri-methylation may have on the BCA assay response. 
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STRUCTURE ELUCIDATION OF PROTEIN-PROTEIN COMPLEXES BY PARAMAGNETIC 
RELAXATION ENHANCEMENT NMR 
5.1. Introduction 
5.1.1. Protein-Protein Interactions and Their Significance 
 With over 80% of proteins carrying out their respective metabolic functions through the 
formation of complexes, the study of protein-protein interactions (PPI’s) is a field of great 
interest as it allows for in depth understanding of metabolic pathways.3 PPI’s often dictate the 
function and activity of proteins, thus the occurrence of PPI’s mitigates specific functions that 
can be categorized by the purpose they serve.4 The modification of the kinetic properties of 
enzymes aids in the general mechanisms of channeling substrates, construction of new binding 
sites for small molecules, inactivation or suppression of a protein function, or to act in regulatory 
roles. As proteins are involved in nearly all biologically processes, such as those which cause 
disease, one of the most prevalent uses of the knowledge and understanding of PPI’s  is for the 
identification of drug targets to provide for the discovery of new approaches to treatments and 
cures.5 The focus of the work detailed herein is on PPI’s, which act to inactivate or suppress 
protein function. Specifically, the interaction that is central to this work occurs between a 
cysteine protease and a cysteine protease inhibitor. 
5.1.2. Proteases 
Proteases are a group of proteins characterized by their catalytic function of hydrolyzing 
peptide bonds to break down proteins.6 Found in almost every living organism, proteases are 
broadly generalized based on how they cleave the peptide bond. Exopeptidases break down 
protein starting from either the N-terminus, such as aminopeptidases, or the C-terminus, like 
carboxypeptidases. Proteases, which cleave peptide bonds from within the sequence and/or at 
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specific points, are endopeptidases. An example of an endopeptidase is trypsin.7 Serine, 
threonine, aspartate, glutamic acid, metallo-, and cysteine proteases are the six broad classes of 
proteases classified based on the catalytic residue within their active sites.8-9 The focus of this 
work involves a cysteine protease, which will be discussed in detail in the following section. 
5.1.3. Cysteine Proteases 
As one of the six broad classes of proteases, cysteine proteases are typically between 21- 
30 kDa in mass and tend to show the most hydrolytic activity at pH values between 4 and 6.5.8 
As with proteases in general, they are found in almost all living organisms and to date, 21-30 
different families have been identified, with the majority derived from viruses.9-11 The cysteine 
protease involved in the work described herein is isolated from the latex of the papaya fruit, 
Carica papaya. Its structure, similar to papain isolated from other sources in both shape and 
sequence, consists of a single amino acid chain that is 212 residues in length with a mass of 23 
kDa.1, 12 The single amino acid chain folds into its tertiary structure which consists of both a right 
and left domain separated by a catalytic cleft containing the catalytic dyad, Cys 25 and His 159. 
The structure of papain is illustrated in Figure 5.1.1  
The catalytic function of cysteine proteases is accomplished through a nucleophilic attack 
by the catalytic cysteine to covalently bind the protease to the protein substrate, whereby there is 
a release of the C-terminal fragment of the protein and an acyl-enzyme intermediate. The 
intermediate then undergoes a second hydrolysis, completing the catalysis and releasing the 
starting protease along with the N-terminal fragment of the portion of the protein.13-14 A 
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Cysteine proteases participate in various metabolic functions and have also been 
implicated in the development and progression of diseases in which there is abnormal protein 
turnover.15-17 The proteolytic action of cysteine proteases can be impeded by inhibitors through 
the formation of protease-inhibitor complexes.  
5.1.4. Protease Inhibitors and Cysteine Protease Inhibitors 
Despite their important biological roles, the actions of proteases, when not regulated, can 
be harmful. The most prevalent mechanism for the regulation of these catalytic enzymes is their 
binding interactions with inhibitors.18 To date, there have been thousands of manuscripts 
published on hundreds of known inhibitors. The research efforts in this field are mainly fueled by 
the applicability of the inhibitors to the fields of medicine, agriculture, and biotechnology.18 
Structural studies pertaining to the complexes formed by a protease and an inhibitor may be 
helpful in the discovery of synthetic mimics for drug development. Abnormalities in the behavior 
of inhibitors have been implicated in the development and progression of several diseases, 
including emphysema and epilepsy.19-20 The manner in which inhibitors are classified continues 
to be improved. Currently 67 families are classified based on amino acid sequence similarities. 
From these families, inhibitors are further grouped into 38 classes based on similar tertiary 
structures.21 Inhibitors of cysteine proteases are referred to as cystatins, as homage to the first 
identified cysteine protease, cystatin, which was isolated from chicken egg white. Early studies 
indicated that it was a fervent inhibitor of proteases within the papain family.22 In 2001, 
Monteiro and coworkers published work identifying a new family of inhibitors of cysteine 
proteases, the chagasin family. Members of this family are more commonly known as inhibitors 
of cysteine peptidases (ICP).23 This family of inhibitors of cysteine proteases demonstrates the 
ability to function as inhibitors to the proteolytic actions of cysteine proteases like papain. Yet, 
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despite their similar inhibitory behavior to other families known to bind papain and papain like 
proteases, there are no significant sequence similarities. Members of the chagasin family of 
inhibitors are isolated from a limited number of sources; parasitic protozoa, bacteria, and 
archaea.24 What remains a mystery about this particular family is whether their inhibitory 
functions serve the parasite as in the case of the protozoan parasite, Trypanosma cruzi, or the 
host as suggested by work done on the parasite Leishmania mexicana.24-25 Some work has also 
been done suggesting that the ICP from pathogens play active roles in the progression of 
infection by the bacteria.2  
 Previous studies of the binding of ICP isolated from various sources have suggested that 
the ICP may bind to the protease via conserved loops of the protein’s secondary structure.26-28 
The ICP involved in the work described herein is derived from the protozoan parasite, 
Leishmania mexicana. The sequence similarity has minimal overlap with ICP from different 
sources despite similar three dimensional structures, suggesting the presence of structural regions 
important for function. In 2006, Brian O. Smith and coworkers published work presenting the 
structure of ICP from Leishmania mexicana solved by nuclear magnetic resonance spectroscopy 
(NMR). Smith’s work also identified the conserved loops, F-G, B-C and D-E, shown in Figure 
5.3. A. To show the structural similarities of ICP and other inhibitors, which serve in the same 
inhibitory roles, Figure 5.3. A illustrates the overlay of the binding loops with those of stefin B, 
which is another inhibitor of cysteine proteases from the cystatin family. In an attempt to solve 
the structure of the complex formed by papain and ICP, Smith and coworkers conducted 1H-15N 
heteronuclear single quantum coherence (HSQC) NMR experiments in order to monitor the 
appearance of spectral peak perturbations when ICP is complexed with papain in comparison to a 
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Figure 5.3 B. The structural similarities of ICP and stefin B, an inhibitor which is known to also 
bind papain, led Smith and coworkers to investigate the similarities in the binding motifs of the 
two inhibitors. Using HADDOCK (high ambiguity data driven biomolecular docking) data from 
the perturbations studies and the crystal structure of the complex formed by stefin B and papain 
were used to model the binding of the complex shown in Figure 5.3 C. Results from these 
docking experiments suggest that ICP binds papain in the same manner as stefin B, where the D-
E loop interacts with the active site of papain. With two conflicting sets of data, there is still no 
definitive structure of the complex. This is the primary motivation behind this work. 
5.1.5. Project Overview 
 The main objective of the work described in this chapter is to develop a method that will 
allow for the determination of the quaternary protein structure using NMR spectroscopy. Similar 
to the work presented in the previous chapters of this dissertation, this method employs the use 
of reductive methylation, a chemical modification reaction, which results in the addition of two 
methyl groups at the primary amino groups of the lysine side chain and the N-terminus.30 The 
structural complex that is instigated is formed by papain and ICP. In addition to reductive 
methylation, a second protein modification reaction is employed. Site directed spin labeling 
(SDSL) is a protein modification reaction by which a paramagnetic spin label is introduced to the 
protein structure. Figure 5.4. illustrates the proposed method in which  both proteins are labeled 
and the methyl groups of the reductively methylated papain yield dimethylamine NMR peaks. In 
the presence of the paramagnetic tag attached to the structure of ICP, distance dependent 
perturbations of the 13C dimethylamino groups within 24 Å of a methyl group can be measured. 
The resulting spectral changes are a result of an increase in nuclear relaxation, resulting in 
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Traditionally, many of these distances were determined by two dimensional NMR experiments 
using the nuclear Overhauser effect (NOE).33 However, only distances to ~5 Å are measurable 
using this technique. Longer distances are desirable especially to dock two known structures.34 
Paramagnetic relaxation enhancement (PRE) NMR allows for the measurement of distances up 
to 35 Å, depending on the paramagnetic tag utilized and the binding kinetics. The paramagnetic 
effects are a result of the strength of the paramagnetic moment of the probe in comparison to the 
magnetic moment of the nuclear spins.35-37 Observed spectral changes using PRE NMR are the 
result of magnetic dipolar interactions, which occur between the observed nucleus and an 
unpaired electron of a paramagnetic moiety attached to the protein. There are two types of probes 
that can be bound to the protein to yield the paramagnetic spectral effects, metal ions and free 
radicals.38-39 The attachment of one of these groups results in an increase in the relaxation of the 
observed nuclei. The enhancement of the relaxation of the nuclei is proportional to 1/r6, where r 
is the distance between each nucleus and the unpaired electron. Visually, the paramagnetic 
effects of the tag result in the distance dependent broadening of the spectral peaks. The visual 
results are quantified by measuring the change in the transverse relaxation, when the 
paramagnetic center is active versus when it has been reduced to its diamagnetic state.40-41 As 
mentioned previously, there are two types of paramagnetic probes that can be used for PRE 
studies: paramagnetic metal ions, such as manganese (Mn+2) or gadolinium (Gd+3) and free 
radicals.42 Using paramagnetic metals as probes requires the protein to have a metal binding site. 
Since not all proteins have the ability to bind metal ions, this labeling method is not always 
efficacious. Free radicals serve as an alternative for the introduction of a paramagnetic moiety 




5.1.7. Site Directed Spin Labeling 
Site directed spin labeling (SDSL) can be simply defined as the covalent attachment of a 
paramagnetic spin label to a specific site on the structure of a biomolecule, in this case, proteins. 
A spin label is a chemical compound that has a stable radical. The introduction of a spin label to 
the structure of the protein allows for analysis by PRE NMR. The first stable nitroxide 
paramagnetic compounds were synthesized in Russia in the 1960s.44 These spin label precursors 
act as the reactive groups in the spin labels used today. The first spin label was prepared in 1965 
by McConnell and coworkers.45 A couple of years later in 1967, they were one of the first to 
publish work demonstrating the applicability of the attachment of spin labels. In their work, they 
investigated  the conformational changes of hemoglobin due to oxygen binding.46 While the 
majority of spin labels are nitroxides, other labels have been developed to bind to a number of 
reactive groups. Hubbell and coworkers pioneered the widespread use of spin labeling to study 
protein structure by using mutagenesis to insert a cysteine into the sequence. This discovery 
made the method of SDSL an invaluable tool for the field of structural biology.47 The most 
widely targeted amino acid for the attachment of a spin label is cysteine. There are three types of 
spin labels that have been developed to react with the thiol groups of cysteine residues: 
maleimides, alpha halo-acetamide groups, and disulfide based reagents.48 Of the three, reagents 
that react to form a disulfide bond at the attachment site with the sulfhydryl group are the most 
routinely used for labeling. This is mostly due to the fact that the other two types also react with 
the amino groups of lysines residues and the hydroxyl groups of serine, threonine, and tyrosine 
residues, in addition to the thiol of cysteine residues.48 The additional reactive groups of 
maleimides and the alpha halo-acetamide groups are typically found in higher abundance within 
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The wide range of capabilities of SPR increases the applicability of the system to study an array 
of biomolecules and their various interactions.51-60 
5.1.9. Surface Plasmon Resonance -Theory 
SPR spectroscopy functions based on the excitation of surface plasmons which result 
from the reflection of a beam of plane polarized light off a metallic surface, such as gold, into a 
second medium with a lower refractive index, under the conditions of total internal reflection. 
The first observation of surface plasmons was in 1902 by Wood, who reported spectral 
anomalies when light was diffracted from a metal grating.61 Fano later demonstrated the 
anomalies to be a result of the excitation of electromagnetic surface waves on the grating.62 The 
works of Kretschman, Otto, and Raether are considered the significant push towards the 
development of the modern optics of today.63-64  The instrument used in this work is the Biacore 
X100, which employs the SPR Biosensor technology. This instrumentation allows for the 
detection and quantification of bimolecular interactions in real time. In addition, this analytical 
technique does not require the use of labels for analysis.65 Such analysis is made possible by the 
three most important components of the system: the optical detector, the sensor chip, and the 
microfluidic system. Each of these components is integral to the analysis of the bio-molecular 
interactions. 
5.1.10. The Sensor Chip and Detection System  
The sensor chips used in Biacore systems are exchangeable components that are 
functionalized to have an affinity for a selective ligand molecule. The chip used for the work 
presented within this chapter is a nitrilotriacetic acid (NTA) chip. This chip was chosen due to its 
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5.1.11. Electron Paramagnetic Resonance Spectroscopy 
The lone electron of the nitroxide spin label is detected by electron paramagnetic 
resonance (EPR) spectroscopy, allowing for the quantitation of the spin labeling reaction. 
Electron paramagnetic resonance (EPR) spectroscopy, sometimes also referred to as electron 
spin resonance (ESR) spectroscopy is a technique similar to that of NMR. The most significant 
difference between the two techniques lies in the fact that while NMR is characterized by the 
detection of the nuclear spins, EPR detects the spins of unpaired electrons like those found 
within a paramagnetic metal or nitroxide spin label. Another major difference in the method is 
the type of radiation used to excite the sample: NMR utilizes radio frequency energy and EPR 
uses the microwave radiation. However, the working principles of the two techniques are similar. 
Like NMR, the introduction of an external magnetic field splits the energy state of the electron 
spin into two energy states, high or low. When the energy difference between the two states is 
equivalent to the microwave radiation, transitions occur or rather energy absorption occurs. The 
energy absorption of this technique is shown by spectra that are the first derivative of the 
absorption spectrum.42 
5.2. Methods and Materials 
5.2.1. Reductive Methylation of Papain 
Reductive methylation of papain from Carica papaya (Sigma) was performed using a 
protocol similar to that outlined in Chapter 2 Section 2.2.1. In short, a 5 mg/mL stock solution of 
papain was prepared in 50 mM potassium phosphate buffer at pH 7.5. Fresh stock solutions of 
dimethylamine borane complex (Sigma) and 13C labeled formaldehyde (Cambridge Isotope 
Laboratory) were prepared in Millipore water at a concentration of 235 mM and kept on ice. A 1 
mL aliquot of the protein stock solution  was used for the reaction and was labeled using a molar 
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ratio equivalent to 1:8, lysine to formaldehyde, by the 9.8 mM addition of DMAB and 18.8 mM 
addition of 13C formaldehyde. The sample was allowed to incubate for 2 hours, while rotating at 
4 °C. Following the incubation period, a second addition of DMAB and 13C formaldehyde was 
added to the sample, equivalent to the concentration of the previous additions, followed by a 
second 2 hour incubation period. A third and final addition of DMAB was added to the sample at 
a concentration equivalent to 4.7 mM after which the sample was allowed to incubate overnight, 
at 4 °C while mixing, for a total reaction time of 24 hours. After 24 hours, an aliquot of a freshly 
prepared 253 mM solution of ammonium sulfate (Sigma), equivalent to 10 mM, was added to 
quench the reaction. The sample was then incubated for an additional hour at 4 °C while mixing 
followed by exchange into a 20 mM succinate, 150 mM sodium chloride buffer at pH 5.0 for 
further analysis. The reaction was quantified using matrix assisted laser desorption ionization 
mass spectrometry (MALDI MS). Based on the change in mass from the unmodified to the 
modified protein, papain was calculated to be ~ 94% modified.  
5.2.2. Expression of ICP  
The C56S, E102C, K27C, K8C, and T61C mutants of Leishmania mexicana ICP were 
expressed from a pET28 (Novagen) derived plasmid in C4 Escherichia coli cells.(Lucigen).2 The 
plasmids were gifted by the Smith group from the University of Glasgow, UK. Cells were grown 
in 1L of LB broth with kanamycin to an optical density at 600 nm of 0.6-0.8 followed by 
induction with isopropylthiogalactoside (IPTG) at 37 °C for 3 hours.67-68 Cells were 
harvested by centrifugation at 3000 x g for 15 min and kept at -80 °C until lysis. SDS-PAGE 





5.2.3. ICP Purification  
The E. coli cells were lysed in 20 mL of lysis buffer (10 mM Tris (Sigma), 150 mM sodium 
chloride (NaCl) (Sigma), and 10 mM imidizole (pH 7.5), 2mL of Bugbuster (Novagen), 100l 
of Complete EDTA-free protease inhibitor (Roche), and 15L DNAase (Fischer)). Cells were 
allowed to incubate at room temperature for 20 minutes before ultrasonic disruption and high 
pressure homogenization to complete lysis. Cell debris was separated from the protein by 
centrifugation at 35,000 x g for 30 minutes, twice. The supernatant was filtered using a 0.2 m 
filter to remove any remaining solid particulates. Purification of the ICP from the cleared 
supernatant was first achieved using 4 mL of His Pur cobalt resin (Thermo Scientific). The 
column was equilibrated with using 2 bed volumes of 10 mM Tris, 150 mM NaCl buffer at pH 
7.4 (equilibration/load buffer). The cleared cell lysate was loaded to the column and then washed 
twice using two bed volumes of the load buffer. The protein was then eluted in twice using two 
bed volumes of 10 mM Tris, 150 mM NaCl, 500 mM imdizole, pH 7.4. The eluant from the 
cobalt purification was further purified using a HiPrep 26/60 Sepahacryl S-100 gel filtration 
column with 20 mM potassium phosphate, 150 mM NaCl, pH 7.2 as the running buffer. 
Fractions containing ICP were collected and combined. A 20 mL volume of the pooled fractions 
were dialyzed against 20 mM succinate, 50 mM NaCl, pH 5.0 buffer using Amicon centrifugal 
filters with a 3 kDa molecular weight limit (Millipore). Chromatograms of purifications and SDS 
PAGE gels of the collected fractions are in Appendix III in Figures A.3.1. – A.3.4. 
5.2.4. Spin Labeling of ICP 
For the attachment of the spin label, MTSL, the concentration of the ICP was determined 
using the Bradford assay. A 15x molar excess of tris(2-carboxyethyl)phosphine (TCEP), from a 
500 mM solution in Millipore water, was added to the protein solution. The samples were then 
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incubated at room temperature for at least 5 minutes followed by immediate desalting on a 8 mL 
P4 column using a 20 mM succinate, 50 mM NaCl buffer at pH 5.0 for the removal of TCEP. 
The protein concentration was again determined using the Bradford assay. An aliquot of MTSL, 
equivalent to a 20x molar excess was added to the ICP from a 37.8 mM stock solution of MTSL 
in 100% acetonitrile (ACN). Each sample was incubated for approximately 15 hours at 4 °C. 
Subsequently, samples were dialyzed against 20 mM succinate, 50 mM NaCl, pH 5.0, using 
Amicon centrifugal filter tubes with a molecular weight (MW) cutoff at 3 kDa, to remove 
unreacted MTSL.  
5.2.5. Analysis by Surface Plasmon Resonance Spectroscopy 
In preparation for SPR analysis, all buffers were prepared fresh, including the 
immobilization buffer (10 mM HEPES, 0.005% Tween 20, 0.15 M NaCl, and 5 M EDTA, pH 
8.5), conditioning buffer (0.35 mM EDTA), regeneration buffers (0.5 M EDTA and 0.1 M 
sodium hydroxide), and an activation buffer (5 mM nickel (II) chloride in immobilization 
buffer). Analysis of the binding interaction between the spin labeled ICP mutant and reductively 
methylated papain (RM-papain) was compared to the binding interaction occurring when the two 
proteins were unlabeled. Prior to analysis, the concentration of each sample was determined by 
using the Bradford assay. Dilutions of ICP were made from a 1000 nM stock in immobilization 
buffer to make a 3 nM solution for the study of the labeled protein. For the analysis of the 
unlabeled complex, 30 nM of ICP was used. The concentration of RM-papain was also 
determined via the Bradford assay, as the quantitation by other colorimetric protein assays, such 
as the bicinchoninic acid (BCA) assay, is skewed by the reductive methylation modification (See 
Chapter 4). A 1000 nM stock of RM-papain was made in immobilization buffer and then used to 
make 5, 10, 20, 40, and 80 nM solutions of RM-papain to study the binding interaction with the 
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MTSL-labeled ICP protein samples. For the analysis of the unlabeled proteins, 20, 25, 30, 35, 
and 40 nM dilutions of papain were used. SPR analysis was conducted using a nitrilotriacetic 
acid (NTA) sensor-chip (Xantec) on a Biacore X100 instrument using single-cycle kinetics 
experiments on the Biacore X100 Control software.  The single-cycle kinetics experiment 
requires no regeneration of the surface following the addition of increasing concentrations of 
analyte. Sensorgram analysis was achieved using the Biacore X100 Evaluation software, by 
which the experimental data was processed and fit using a 1:1 binding model for the calculation 
of experimental parameters, including ka, kd, KD, and Chi
2. 
5.2.6. Sample Preparation for Analysis by EPR 
Calibration standards at 1, 3, 5, 7, 9, and 10 M were made from the 37.8 M stock 
solution of MTSL to 1 mL, using 20mM succinate, 50 mM NaCl, pH 5.0 buffer. Each calibration 
standard was made in triplicate in order to construct a calibration curve from which the 
concentration of the spin label on the mutant ICP was calculated.  
5.2.7. NMR Analysis 
Reductively methylated papain and spin labeled ICP mutants were prepared for analysis 
by NMR by exchange into 20 mM succinate, 50 mM NaCl, pH 5.0 buffer in D2O using Amicon 
spin filters with a MW limit of 3 kDa. The concentrations of the proteins were determined using 
the standard Bradford assay protocol. NMR samples were made to 500 L, where half of the 
sample volume was from ICP and the other from papain at a molar concentration ratio of 1:0.9 
ICP to papain. 2D 1H-13C heteronuclear single quantum coherence spectra were acquired on a 
700 MHz Varian spectrometer equipped with a room temperature 5 mm HCN probe using a 
relaxation delay of 5 seconds, 220 increments in the 13C dimensions, and a total of 8 scans. Each 
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spectrum was processed using MestReNova software.  The total experiment time was 5 hours 
and 33 minutes. For each sample, two spectra were recorded, one in which the paramagnetic tag 
was active (in its paramagnetic oxidized form) and a second in which 5 mM sodium ascorbate in 
D2O at pH 5, was added to reduce the nitroxide of the reagent (non-active or diamagnetic). 
5.3. Results and Discussion 
5.3.1. SPR Binding Studies 
Single-cycle kinetic experiments were conducted on the K8C, K27C, E102C, T61C, and 
C56S mutants. Five trials were completed for the binding studies involving the unmodified 
papain and C56S mutant. Three trials were conducted for the binding studies involving the K8C, 
E102C, and T61C mutants, while only two were conducted involving the K27C mutant. Table 
5.1 lists the average rate of association, average rate of dissociation, and average equilibrium 
dissociation constant. In addition, the average Chi2 value of the trials conducted is also listed. 
Higher values for the rate of association indicate a faster binding interaction between the two 
molecules being studied. Lower values for the rate of dissociation indicate a slower rate of 
dissociation, while lower equilibrium dissociation quantifies how tight the binding interaction is. 
In comparison to the unmodified construct, the K8C, K27C, E102C and the T61C mutants 
exhibited a slight decrease in the rate of association. The rate of dissociation of all of the 
cysteine-containing mutants was also slightly lower in comparison to the unmodified construct. 
The equilibrium dissociation constants for all mutants were comparable to each other, and values 
were consistently higher than for the unmodified construct, which indicates a slight decrease in 
the affinity of the interaction between ICP and papain when the proteins are modified. This 
decrease in affinity could be attributed to the addition of the MTSL spin label and the 13C methyl 
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 Preliminary experiments to quantify the SDSL reaction for the addition of MTSL were 
conducted on the K8C, K27C, E102C, and T61C mutants of ICP. These experiments were 
conducted on a Bruker X Band EPR instrument. In short the method involved making calibration 
standards of MTSL at concentrations of 1, 3, 5, 7, 9, and 10 M in 20 mM succinate, 50 mM 
NaCl buffer at pH 5.0 from a 37.8 mM stock solution of MTSL, in triplicate, in order to generate 
a calibration curve. An example of the curves generated is shown in Figure 5.9. The data points 
on the curve were fit using the linear least squares analysis to calculate the slope, intercept, and 
correlation coefficient (R2). Labeled ICP samples were then analyzed by EPR. The sum of the 
integration values of the spectral signals was used to calculate the concentration of MTSL. Using 
a calibration equation, determine the percent of the labeling was calculated.69 The results from 
the EPR experiments to determine the percent labeling of the four mutants are shown in Table 
5.2. Not only do the results indicate that the labeling method is successful in modifying the 
structure of ICP with the spin label, it also shows that the spin label can be successfully 
quantified using this method. Future NMR studies would be most beneficial if the extent of spin 



































Concentration of MTSL (M)
Calibration Curve of MTSL Standards
Figure 5.9. Calibration curve of the standards made at 1, 3, 5, 7, 9, and 10 M concentrations 
of MTSL versus the average second derivative of the absorption. 
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labeling was known prior to analysis. EPR spectra of standard and protein samples are shown in  







5.3.3. NMR Analysis 
 The importance of the cysteine mutants for this study is that it allows for the attachment 
of the paramagnetic spin label to different sites on the structure of a protein, from which multiple 
distances to nearby nuclei of interest can be measured. Of the five cysteine-containing mutants 
available for study, analysis of four is presented. The results detailed in this section focus on 
comparing spectra of the complex formed by a cysteine mutant of ICP and papain with an active 
paramagnetic tag versus spectra with the tag reduced. The peaks observed in the spectra show the 
13C labeled dimethylamine groups of reductively methylated papain. Figure 5.10. displays a 2D 
1H-13C HSQC NMR spectrum of a reductively methylated sample of papain. Within the 
sequence of papain, there are 10 lysine residues, which along with the N-terminus, gives the 
protein 11 reaction sites that are labeled in the spectrum. The slow exchange of the added methyl 
groups causes peak splitting, which is why more than 11 peaks are observed. The numbering 
Table 5.2. Percent Labeling 











scheme presented in Figure 5.10 will be used to identify peaks, which exhibit perturbations. 
Efforts towards determining which mutants yielded the paramagnetic effects were accomplished 
through preliminary 2D 1H-13C HSCQ NMR experiments for the K8C, K27C, E102C, and the 
T61C mutants. A 2D 1H-13C HSQC overlay of the K8C mutant of ICP and papain is shown in 
Figure 5.11. The red spectrum represents a sample in which the paramagnetic tag is active. The 
black spectrum shows the same sample to which a 5 mM addition of ascorbic acids was added to 
quench the labeling reagent. The spectra in Figure 5.11 are very similar in regard to most peaks. 
The peaks 8 a-b and 9 a-b are slightly less intense in the spectrum shown in red. The low 
intensity could possibly be due to low levels of the spin label incorporation, or because the 
position of the label is outside the distances that the paramagnetic effects of the tag (>24 Å). The 
spectral overlay of the K27C mutant and reductively methylated papain is shown in Figure 5.12. 
Contrary to the results presented for the K8C mutant, multiple peaks within the spectrum exhibit 
peak perturbations. With the exception of peaks 1, 2 and 7, every peak in the spectrum is 
changed when the spin label is active. The most drastic effect can be observed by the total 
disappearance of peak 11. Peaks 4 – 6, which are highlighted in the insets A and B (due to the 
degree of peak overlap) also show decreases in peak intensity. The data from this figure suggests 
that the K27C position in the sequence of ICP is within 24 Å of many of the reductively 
methylated lysines of papain when the complex, is formed. The results also suggest that distance 
measurements can be determined to multiple sites on this complex, which will be helpful for 
docking studies to model the complex structure. Though the numbers of perturbations are not as 
many as observed with the K27C mutant, the spectral overlay shown in Figure 5.13 of the 
complex formed by the E102C mutant shows changes in the peak intensities of peaks 4 a-b and 
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when both proteins are unlabeled, p-values calculated at the 95% confidence interval show that 
statistically there is no difference, which indicated binding is not affected by the introduction of 
the chemical modifications. 2D NMR studies were conducted to observe the effects of the 
paramagnetic tags on the spectra when the tags were active versus they were reduced to their 
diamagnetic state. Each of the four mutant proteins studied have spectra where the peaks 
changed when the magnetic state of the spin label was altered. These results demonstrate that the 
method presented is viable and can be a useful tool used to for the determination of the 
quaternary structure of proteins. 
5.5. Future Work 
While the results presented demonstrate the feasibility of this technique, additional work 
must be done to demonstrate its applicability. In order to solve the quaternary structure of the 
complex formed by papain and ICP using NMR, additional NMR experiments are necessary. 
Once the peak assignments of reductively methylated papain is achieved, the addition of the 
MTSL label to ICP, as stated before, has distance dependent effects on the relaxation of nuclei of 
the 13C methyl groups. These effects can be adequately measured through the measurement of 
the T2 relaxation time of the spectral peaks when the paramagnetic tag is active tag versus when 
it is reduced to its diamagnetic state. The changes in relaxation times can be used to calculate the 
distances between the paramagnetic tag and 13C methyl groups within 24 Å. The distances 
calculated can be used as restraints for computational docking experiments in order to model the 
structure of the protein complex. 41-42, 70-71  
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This dissertation has presented work focused on the development and identification of 
tools useful for protein structural studies. The development of these tools centers on the chemical 
modification reaction, reductive methylation. The utility of this reaction has been demonstrated 
for various structural studies. The work detailed throughout this dissertation is of additional work 
that addresses some of the limitations of the labeling method and presents a novel use for the 
labeling method. The first chapter serves as an introduction to proteins and their structure. It goes 
on to focus on side chain reactivity, highlighting the target of certain “R” groups as sites for 
protein modifications, both naturally occurring and chemically induced. The latter part of the 
chapter provided as more in-depth discussion of reductive methylation, a reaction that selectively 
modifies the side chain of the lysine residues, discussing the reaction’s previous use for protein 
study in order to establish the importance of this dissertation work in relation to what has 
previously been done. 
Chapter 2 goes on to detail a project focused on the development of a method for the 
assignment of lysine residues to NMR peaks with the aid of solid chromatographic media, 
nuclear magnetic resonance spectroscopy (NMR) and matrix assisted laser desorption ionization 
mass spectroscopy (MALDI-MS). The overall goal of the project was to overcome the labeling 
degeneracy often encountered when using reductive methylation. To do this, four 
chromatographic media were introduced into the reaction mixture in order to enhance the 
variation in the degree of labeling at the reaction sites. Of the media tested, G-15 Sephadex and 
Lipophilic Sephadex showed the most promise in comparison to the studies involving G-75 
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Sephadex and C18 Silica. Studies using G-15 Sephadex and Lipophilic Sephadex initially 
showed promise, indicating that not only was labeling inhibited by the presence of the media in 
the reaction mixture, but also that there was variation in the levels of methylation of the intact 
protein. Studies in which the amount of media was varied from 10 mg to 100 mg also indicated 
that these conditions had an inversely proportional relationship with labeling. Studies that 
compared the degree of methylation at each residue determined by MALDI MS of tryptic 
peptides with the degree of labeling present at each NMR peak suggested that while there is a 
distinct decrease in the levels of methylation when media is present, versus when the media was 
absent. In addition, the differences observed between the Lipophilic and G-15 Sephadex samples 
in the initial studies were not reproduced, but instead gave percent methylation values that were 
comparable. In regard to the goal of breaking the labeling degeneracy, this was achieved in the 
MALDI MS data, which gave values that were statistically distinct with a 95% confidence. 
However, the NMR data for three of the seven peaks has similar methylation values that were 
not statistically distinguishable which lead to their tentative assignment. Overall, this method 
was only able to definitively assign two of the seven lysine residues of the protein to NMR 
peaks. Future outlooks of this project could be to try breaking the labeling degeneracy by making 
the assignment thought the comparison of a samples labeled in the presence of media to one 
labeled in the absence of media. In addition, since the NMR data proved to be the limiting factor 
in data analysis, alternative analysis methods to determine the percent methylation could be 
explored.  
The third chapter of this dissertation details work towards improving the resolution of the 
dimethylamine peaks in the NMR spectra. Various methods were used such as increasing the 
sample temperature and varying sample pH. In addition, the effects of additives such as EDTA 
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and cobalt were studied. While some methods such as the increase in sample temperature helped 
to improve peak intensity, others techniques such as the addition of EDTA helped to resolve 
peak overlap. Both the addition of cobalt and the variation of sample pH proved to play a role in 
chemical shift changes and peak resolution. This work demonstrated a set of tools that can be 
explored when spectral resolution is problematic. The most notable finding of this work 
demonstrated that contrary to previously published work that asserted that the best resolution of 
the dimethylamine peaks is achieved when the sample pH is in the range of pKa of the lysine side 
chain. In chapter 4, a practical issue was addressed through the investigation of the effects of 
reductive methylation on the determination of protein concentration. Experiments were 
conducted to observe the effect of reductive methylation on absorbance values, which are 
inadvertently used to calculate protein concentration in both the Bradford assay and the 
bicinchoninic acid (BCA) assay. Results from these studies indicated that the protein 
concentration determined for the RM protein by the BCA assay were statistically higher than 
those determined for the unmodified proteins were assayed. The comparison of the protein 
concentrations determined for the modified and unmodified proteins using the Bradford assay 
resulted in concertation determinations that were comparable. Thus, the overall implication of 
this work is that the posttranslational modification (PTM) of methylation, which is common in 
nature, can be problematic and should be taken into consideration when choosing a colorimetric 
assay to quantify protein.  
The final chapter of this dissertation work outlines the development of a novel method for 
protein structure determination using both reductive methylation and paramagnetic relaxation 
enhancement (PRE) NMR. This work involves two proteins, a cysteine protease and a cysteine 
protease inhibitor, which are known to bind to one another. The primary objective of this project 
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was to develop a method that utilizes both reductive methylation and site directed spin labeling 
(SDSL), in order to establish a method for the determination of the quaternary structure for the 
complex. In addition to the development of the NMR method, the kinetics of the binding 
interaction was also studied using surface plasmon resonance (SPR) spectroscopy. Electron 
paramagnetic resonance (EPR) spectroscopy is a third technique that was used in order to 
quantify the SDSL reaction. Results obtained from the SPR studies demonstrated that the 
introduction of the labels to both the proteins caused minimal disturbance to the binding 
interaction of the two proteins. An optimized SDSL labeling protocol gave EPR results that show 
that greater than 75% labeling of mutant constructs of the cysteine protease inhibitor by the spin 
label was attained. The NMR data showed that binding of the cysteine protease to four mutants 
constructs of the inhibitor exhibited the hypothesized paramagnetic effects on the NMR signals 
with the introduction of the spin label. These results provide evidence that this method can be 
used to determine the distances between the label and the affected 13C dimethylamine groups, 
which can be used as distance restraints for the computational structure determination.  
In whole, this dissertation presents work towards broadening the tool set of how the 
reductively methylation reaction can used for the study of protein structure. Though the work 
presented here is not necessarily applicable to all proteins, the findings can be considered as 









Method A.1.1. Desalting Protocol Using C18 Spin Columns .....................................................160 
Tables 
 
Table A.1.1. Percent Methylation and Standard Deviation Values of Reductively 
Methylated Hen Egg White Lysozyme using 2.5 mM 
13
C Labeled Formaldehyde 
Determined by NMR and  
MALDI MS ..................................................................................................................................161 
Figures 
Figure A.1.1. - Figure A.1.56. MALDI MS spectra of trial I - IV samples from the 
preliminary studies of reductively methylated hen egg white lysozyme in the presence of 
Lipophilic Sephadex and G-15 Sephadex using increasing concentrations of natural 
abundance formaldehyde - 1.2 mM, 2.5 mM, 4.0 mM, and 9.8 mM  .........................................162 
Figure A.1.57. – Figure A.1.114. MALDI MS spectra of trial I – trial IV samples from the 
preliminary studies of reductively methylated hen egg white lysozyme in the presence of 
C18 Silica and G-75 Sephadex using increasing concentrations of natural abundance 
formaldehyde- 1.2 mM, 2.5 mM, 4.0 mM, and 9.8 mM ..............................................................218 
Figure A.1.115. - Figure A.1.132. MALDI MS spectra of reductively methylated lysozyme 
in the absence of media using 9.8 mM and 2.5 mM natural abundance formaldehyde as 
controls for comparison to samples labeled using 2.5 mM natural abundance formaldehyde 
in the presence of 10 mg and 100 mg of G-15 Sephadex and Lipophilic Sephadex  ..................276 
Figure A.2.133 – Figure A.1.144. 1D 1H-13C HSQC spectra of reductively methylated hen 
egg white lysozyme labeled in the presence of Lipophilic Sephadex and G-15 Sephadex 
using 13C labeled formaldehyde at 9.8 mM and 2.5 mM  ............................................................294 
Figure A.2.145. - Figure A.1.156. MALDI MS spectra of reductively methylated hen egg 
white lysozyme labeled in the presence of Lipophilic Sephadex and G-15 Sephadex using 















































 C18 Spin Colu
4. Wash 
200 µL 


















 Dry Sample 
d Re-suspend 
 MS Analysis 
160 
 
Table A.1.1. Percent Methylation and Standard Deviation Values of Reductively Methylated Hen 
Egg White Lysozyme using 2.5 mM 
13
C Labeled Formaldehyde Determined by NMR and  
MALDI MS
Lysozyme








Peak 1 85.00 1.95 K97 91.77 1.99
Peak 2 66.83 1.52 K33 61.83 0.61
Peak 3 76.71 8.49 K13 66.63 0.85
Peak 4 39.45 4.90 K96 34.87 3.21
Peak 5 60.85 3.38 K116 58.90 0.82
Peak 6 22.77 0.27 K1 22.17 2.65
Peak 7 65.74 2.59 N-Term 60.30 1.82
Lipophilic Sephadex








Peak 1 66.61 2.65 K97 79.40 6.60
Peak 2 52.60 3.96 K33 43.17 1.47
Peak 3 55.24 4.43 K13 54.23 9.91
Peak 4 28.71 1.05 K96 21.70 3.96
Peak 5 42.68 6.22 K116 40.60 0.95
Peak 6 15.57 1.21 K1 15.33 1.66
Peak 7 70.01 5.22 N-Term 55.37 1.19
G-15 Sephadex








Peak 1 64.03 5.28 K97 70.10 1.75
Peak 2 50.76 6.22 K33 44.50 1.65
Peak 3 53.13 7.37 K13 53.43 4.82
Peak 4 26.28 1.49 K96 28.07 6.26
Peak 5 46.40 9.48 K116 40.43 1.04
Peak 6 16.85 2.69 K1 13.30 2.94
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Method A.2.1 Determination of sample pathlengths.  The pathlengths for sample volumes of 
100, 120, and 200 L in 96-well plates were determined using the method of McGown et al. 
(E.L. McGown, J.W. Nelson, J. Williams, and C. Fraser (1997), UV-VIS Spectrophotometry: 
Automated Determination of Pathlength in Microplate Samples, American Laboratory 
29(10):21-24.)  This method is an option in the Gen5 software for the BioTek PowerWave XS2 
microplate spectrophotometer.  Briefly, the absorbance of water at 977 nm and 900 nm are 
subtracted and divided by the known absorbance of water at 977 nm and 1 cm (0.18 Abs) to give 
the pathlength in cm.  The pathlength of replicate samples of water at 100, 120, and 200 L were 
measured in either a half-area or full-area well plate at 25 or 37 C.  The average pathlengths and 
95% confidence levels are summarized in the Table S1.  The average pathlength values were 
used to normalize the absorbance values to 1 cm. 
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half-area 25 100 0.568 0.002 26 
UV-transparent 
half-area 25 120 0.679 0.003 9 
UV-transparent 
half-area 37 120 0.707 0.003 12 
UV-transparent 
full-area 25 200 0.574 0.003 21 
UV-transparent 
half-area 25 200 1.102 0.002 10 
 
 
Table A.2.2 Raw absorbance data for BSA in water at 280 nm and 25 C with the slope, 
intercept, and correlation coefficient calculated using linear regression analysis. 
Concentration (g L-1) in the well Sample 1 Sample 2 Sample 3 
0 0.046 0.045 0.045 
0.2 0.121 0.115 0.117 
0.4 0.190 0.182 0.190 
0.6 0.250 0.248 0.257 
0.8 0.324 0.320 0.327 
1.0 0.396 0.391 0.395 
Slope (g-1 L) 0.3456 0.3444 0.3496 
Intercept 0.0483 0.0446 0.0470 




Table A.2.3 Raw absorbance data for HEWL in water at 280 nm and 25 C with the slope, 
intercept, and correlation coefficient calculated using linear regression analysis. 
Concentration (g L-1) in the well Sample 1 Sample 2 Sample 3 
0 0.045 0.045 0.045 
0.1 0.196 0.195 0.187 
0.2 0.346 0.349 0.331 
0.3 0.490 0.488 0.467 
0.4 0.636 0.633 0.615 
0.5 0.787 0.783 0.754 
Slope (g-1 L) 1.478 1.469 1.419 
Intercept 0.0471 0.0481 0.0452 
Correlation coefficient (R2) 0.9999 0.9998 0.9999 
 
 
Table A.2.4 Raw absorbance data for ovalbumin in water at 280 nm and 25 C with the slope, 
intercept, and correlation coefficient calculated using linear regression analysis. 
Concentration (g L-1) in the well Sample 1 Sample 2 Sample 3 
0 0.046 0.045 0.046 
0.2 0.117 0.121 0.109 
0.4 0.182 0.186 0.18 
0.6 0.254 0.257 0.258 
0.8 0.328 0.325 0.333 
1.0 0.401 0.4 0.401 
Slope (g-1 L) 0.3543 0.3511 0.3607 
Intercept 0.0442 0.0468 0.0408 
Correlation coefficient (R2) 0.9996 0.9996 0.9991 
 
 
Table A.2.5 Raw absorbance data for BSA in buffer at 280 nm and 25 C with the slope, 
intercept, and correlation coefficient calculated using linear regression analysis. 
Concentration (g L-1) in the well Sample 1 Sample 2 Sample 3 
0 0.056 0.055 0.056 
0.2 0.121 0.124 0.120 
0.4 0.186 0.188 0.183 
0.6 0.251 0.259 0.251 
0.8 0.320 0.336 0.321 
1.0 0.402 0.417 0.391 
Slope (g-1 L) 0.3417 0.3596 0.3351 
Intercept 0.0518 0.0500 0.0528 





Table A.2.6 Raw absorbance data for HEWL in buffer at 280 nm and 25 C with the slope, 
intercept, and correlation coefficient calculated using linear regression analysis. 
Concentration (g L-1) in the well Sample 1 Sample 2 Sample 3 
0 0.056 0.056 0.056 
0.1 0.182 0.187 0.184 
0.2 0.314 0.317 0.325 
0.3 0.430 0.436 0.441 
0.4 0.562 0.577 0.574 
0.5 0.676 0.698 0.723 
Slope (g-1 L) 1.245 1.285 1.320 
Intercept 0.0589 0.0571 0.0538 
Correlation coefficient (R2) 0.9996 0.9997 0.9991 
 
 
Table A.2.7 Raw absorbance data for ovalbumin in buffer at 280 nm and 25 C with the slope, 
intercept, and correlation coefficient calculated using linear regression analysis. 
Concentration (g L-1) in the well Sample 1 Sample 2 Sample 3 
0 0.054 0.054 0.054 
0.2 0.123 0.126 0.123 
0.4 0.195 0.196 0.196 
0.6 0.267 0.267 0.269 
0.8 0.335 0.339 0.342 
1.0 0.412 0.423 0.403 
Slope (g-1 L) 0.3569 0.3650 0.3536 
Intercept 0.0526 0.0517 0.0544 
Correlation coefficient (R2) 0.9998 0.9991 0.9993 
 
Table A.2.8 Experimental molar extinction coefficient in mM-1 cm-1. 
Protein 
Experimental280 in 
PBS at 25 C 
(g-1 L cm-1) ± 95% 
confidence interval 
Molecular weight 
based on MALDI 
MS data (g/mol) 
Experimental280 in 
PBS at 25 C 
(mM-1 cm-1) 
BSA 0.61 ± 0.06 66,165 40 ± 4 
HEWL 2.26± 0.17 14,298 32.3 ± 2.4 





Table A.2.9 Raw absorbance data from the Coomassie assay of BSA and reductively methylated 
BSA in buffer at 595 nm and 25 C with the slope, intercept, and correlation coefficient 
calculated using linear regression analysis. 
Concentration (mg L-1) in the well Sample 1 Sample 2 Sample 3 
0 0.242 0.241 0.24 
1.67 0.290 0.292 0.284 
3.33 0.337 0.352 0.350 
5.00 0.385 0.410 0.406 
6.67 0.441 0.462 0.453 
8.33 0.489 0.504 0.496 
Slope (g-1 L) 29.76 32.28 31.59 
Intercept 0.2400 0.2423 0.2399 
Correlation coefficient (R2) 0.9993 0.9973 0.9955 
 










0 0.240 0.253 0.253 
1.69 0.287 0.295 0.287 
3.38 0.340 0.347 0.344 
5.07 0.395 0.396 0.380 
6.76 0.433 0.436 0.425 
8.45 0.477 0.478 0.464 
Slope (g-1 L) 28.38 27.05 25.53 
Intercept 0.2421 0.2532 0.2513 






Table A.2.10 Raw absorbance data from the Coomassie assay of HEWL and reductively 
methylated HEWL in buffer at 595 nm and 25 C with the slope, intercept, and correlation 
coefficient calculated using linear regression analysis. 
Concentration (mg L-1) in the well Sample 1 Sample 2 Sample 3 
0 0.243 0.241 0.241 
1.67 0.298 0.294 0.307 
3.33 0.357 0.349 0.363 
5.00 0.411 0.404 0.419 
6.67 0.449 0.451 0.468 
8.33 0.494 0.490 0.502 
Slope (g-1 L) 30.21 30.36 31.61 
Intercept 0.2495 0.2450 0.2516 
Correlation coefficient (R2) 0.9942 0.9965 0.9909 
 










0 0.241 0.249 0.249 
1.70 0.292 0.295 0.313 
3.41 0.356 0.345 0.352 
5.11 0.409 0.402 0.393 
6.81 0.454 0.444 0.433 
8.52 0.493 0.478 0.473 
Slope (g-1 L) 30.18 27.69 25.54 
Intercept 0.2457 0.2509 0.2600 





Table A.2.11 Raw absorbance data from the Coomassie assay of ovalbumin and reductively 
methylated ovalbumin in buffer at 595 nm and 25 C with the slope, intercept, and correlation 
coefficient calculated using linear regression analysis. 
Concentration (mg L-1) in the well Sample 1 Sample 2 Sample 3 
0 0.233 0.233 0.238 
1.67 0.264 0.262 0.268 
3.33 0.301 0.296 0.309 
5.00 0.339 0.347 0.351 
6.67 0.379 0.382 0.388 
8.33 0.418 0.413 0.425 
Slope (g-1 L) 22.42 22.47 22.92 
Intercept 0.2289 0.2285 0.2343 
Correlation coefficient (R2) 0.9984 0.9939 0.9984 
 










0 0.235 0.272 0.272 
1.69 0.270 0.295 0.308 
3.37 0.310 0.340 0.340 
5.06 0.351 0.368 0.378 
6.74 0.389 0.396 0.415 
8.43 0.429 0.423 0.444 
Slope (g-1 L) 23.19 18.43 20.69 
Intercept 0.2330 0.2713 0.2723 






Table A.2.12 Raw absorbance data from the BCA assay of BSA and reductively methylated BSA 
in buffer at 562 nm and 37 C with the slope, intercept, and correlation coefficient calculated 
using linear regression analysis. 
Concentration (mg L-1) in the well Sample 1 Sample 2 Sample 3 
0 0.092 0.092 0.092 
8.33 0.181 0.185 0.172 
16.67 0.292 0.305 0.285 
25.00 0.392 0.406 0.367 
33.33 0.483 0.505 0.461 
41.67 0.572 0.601 0.557 
Slope (g-1 L) 11.68 12.36 11.23 
Intercept 0.0920 0.0914 0.0885 
Correlation coefficient (R2) 0.9987 0.9989 0.9986 
 










0 0.093 0.096 0.096 
8.45 0.226 0.235 0.223 
16.90 0.378 0.394 0.355 
25.34 0.503 0.526 0.487 
33.79 0.637 0.655 0.602 
42.24 0.756 0.784 0.711 
Slope (g-1 L) 16.02 16.57 14.89 
Intercept 0.0984 0.1032 0.1020 






Table A.2.13 Raw absorbance data from the BCA assay of HEWL and reductively methylated 
HEWL in buffer at 562 nm and 37 C with the slope, intercept, and correlation coefficient 
calculated using linear regression analysis. 
Concentration (mg L-1) in the well Sample 1 Sample 2 Sample 3 
0 0.092 0.092 0.091 
8.33 0.248 0.254 0.264 
16.67 0.389 0.389 0.385 
25.00 0.526 0.526 0.522 
33.33 0.648 0.646 0.648 
41.67 0.765 0.758 0.773 
Slope (g-1 L) 16.12 15.92 16.11 
Intercept 0.1088 0.1125 0.1115 
Correlation coefficient (R2) 0.9972 0.9962 0.9970 
 










0 0.091 0.096 0.096 
8.52 0.300 0.306 0.279 
17.03 0.491 0.496 0.477 
25.55 0.683 0.676 0.668 
34.06 0.832 0.837 0.817 
42.58 0.973 0.996 0.961 
Slope (g-1 L) 21.25 21.51 21.02 
Intercept 0.1190 0.1198 0.1118 




Table A.2.14 Raw absorbance data from the BCA assay of ovalbumin and reductively 
methylated ovalbumin in buffer at 562 nm and 37 C with the slope, intercept, and correlation 
coefficient calculated using linear regression analysis. 
Concentration (mg L-1) in the well Sample 1 Sample 2 Sample 3 
0 0.090 0.091 0.091 
8.33 0.172 0.178 0.189 
16.67 0.274 0.286 0.287 
25.00 0.359 0.37 0.388 
33.33 0.439 0.45 0.462 
41.67 0.523 0.535 0.538 
Slope (g-1 L) 10.46 10.70 10.82 
Intercept 0.0916 0.0955 0.1005 
Correlation coefficient (R2) 0.9987 0.9978 0.9958 
 










0 0.099 0.096 0.097 
8.43 0.247 0.247 0.209 
16.86 0.388 0.401 0.348 
25.29 0.524 0.522 0.490 
33.72 0.661 0.645 0.606 
42.14 0.779 0.763 0.717 
Slope (g-1 L) 16.38 15.94 15.20 
Intercept 0.1086 0.1135 0.0945 
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Figure A.2.4 The mass extinction coefficient at 280 nm (ε 280nm) for BSA, HEWL, and ovalbumin 
measured in water and PBS buffer at 25 C compared to literature values (see references below).  
The ε280nm of HEWL in water and in buffer are significantly different (p = 0.004).  The ε 280nm of 
BSA and ovalbumin were not affected by the buffer and are similar to the literature values.  
 
References for literature values of the mass extinction coefficient at 280 nm: 
 
The Plasma Proteins: Structure, Function and Genetic Control, 2nd ed., Frank W. Putnam, ed., 
Vol. 1, p. 141, 147, Academic Press, New York (1975). 
Aune, K.C., et al., Biochem., 8, 4579-4585 (1965).  Davies, R.C., et al., Biochim. Biophys. Acta, 
178, 294-305 (1969). 
Practical Handbook of Biochemistry and Molecular, Biology, Fasman, G., Ed., CRC Press (Boca 
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